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ABSTRACT
Over centuries, world populations exclusively have used medicinal plants as
therapeutic agents. Currently, some studies have proven that α-mangostin, a natural
xanthone isolated from part of Garcinia mangostana L. tree especially from stem bark or
fruit rinds has many potential activities including antioxidant, anti-bacterial, antivirus, antiinflammatory, and anticancer that has resulted in many mangosteen products appearing on
the market. To standardise and quality control mangosteen and herbal products in general,
an acceptable reference standard which is isolated from the plant itself is required.
Separation and purification techniques using liquid flow processing known as countercurrent chromatography (CCC) are widely applied for this purpose. However, generally
only a single injection of the sample into a CCC apparatus is used due to sample
complexity. Multiple injections to increase the overall yield and scale of the purification are
seldom used. But this has the advantage of reducing the cost of the purification process.
The purpose of this has been to develop an efficient method for production of αmangostin reference standard from fruit rind of Garcinia mangostana L. using liquid flow
processing. The experiment were conducted initially by sample loading studies at analytical
scale using a Mini HPCCC (17.4 mL coil, 0.8 mm bore) with a hexane/ethyl
acetate/methanol/water (5:5:10:4 v/v) solvent system. Extract was prepared by overnight
maceration of mangosteen rinds powder in 80% aqueous ethanol at 30⁰C. The extract in
lower phase was injected up to 10 times without any replacement or topping up the
stationary phase. The studies establsiehd 22.8 mg extract in 0.86 mL lower phase as the
optimum amount of sample with multiple injections; and produced α-mangostin with
98.82% purity and 93.68% yield. Scaled up 8 times with 10 injections on Spectrum-CCC
and 50 times with 7 injections on Midi-CCC gave α-mangostin with 99.24% purity and
96.35% yield; and 98.24% purity and 94.42% yield respectively. The concentration was
then optimised nearly 3 times on Spectrum giving α-mangostin with 98.11% purity and
93.81% yield. These α-mangostin products with purity >98% can be accepted as reference
standard for quality control of mangosteen based products, allowing the precise calibration
of analytical instruments with this target compound. The purified α-mangostin was
identified using commercial reference standard on HPLC and NMR.
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Chapter 1 INTRODUCTION AND LITERATURE REVIEW
1.1 INTRODUCTION
1.1.1 Traditional Herbal Medicines and the need for standard material
The World Health Organization (WHO) defines traditional medicine as, “…the sum
total of the knowledge, skills, and practices based on the theories, beliefs, and experiences
indigenous to different cultures, whether explicable or not, used in the maintenance of
health as well as in the prevention, diagnosis, improvement or treatment of physical and
mental illness”. Herbal medicines include herbs, herbal materials, herbal preparations and
finished herbal products that contain as active ingredients parts of plants, or other plant
materials, or combinations (WHO, 2000). To ensure consistent quality which the active
ingredients have been identified in herbal medicines, WHO requires standardisation to
contain a defined amount of the active ingredients. Therefore, standard material of the
active ingredients from medicinal plants must be provided to meet the needs.
For centuries, medicinal plants have been used as traditional medicines to treat
many diseases. Traditional use refers to the long historical use of these medicines. Their use
is well established and widely acknowledged to be safe and effective, and may be accepted
by national authorities (WHO, 2000). Currently, in spite of the exponential development of
synthetic pharmaceutical chemistry, including combinatorial chemistry and microbial
fermentation, 25% of prescribed medicines in developed countries are of plant origin. This
percentage can reach 50% for the over-the-counter (OTC) market (drugs for selfmedication). In fact, it is also estimated that natural products are used in the development of
44% of all new drugs, especially for the preparation of semi-synthetic derivatives.
Nowadays, the pharmaceutical industry fully considers plants as a viable option for the
discovery of new leads (Hostettmann, 2001).
Indonesia has its own traditional medicine which is a generations heritage called
“Jamu”. It is predominantly herbal medicine made from natural materials, such as parts of
plants i.e. roots, leaves, bark, and fruit. Some times, there is also material from the bodies
of animals, such as bile of goat or alligator (Anon2). The Policy of the Jamu is governed by
the Ministry of Health; however the monitoring of the products were undertaken by the the
National Agency of Drug and Food Control of the Republic of Indonesia (NADFC-RI).
1

To anticipate the increasing number of the natural products in the market of
Indonesia, NADFC-RI needs to consider tools for controlling the products. Analytical
methods for controlling the products should be developed especially to ensure the quality,
safety and efficacy as a domain of the institute. However, to apply the methods either
qualitatively or quantitatively, an acceptable reference standard needs to be provided. The
standard can be an active compound (a biologically active molecule which is often the main
ingredients in pharmaceuticals) or a marker compound (a compound used as an internal
standard or to label particular batches) depending on the analytical purposes. Usually, a
marker compound is used to ensure the content of the product, to avoid product
counterfeiting, while an active compound is needed as a standard when the quality and
efficacy of the product needs to be ensured. According to the WHO, if the identification of
an active principle is not possible, then it should be sufficient to identify a characteristic
substance or mixture of substances (e.g. “Chromatographic fingerprint”) (WHO, 2000)
1.1.2 Preparation of standards; a role for Counter-current Chromatography (CCC)
Preparation of a marker or active compound from a medicinal plant is not a simple
task because there will be a long procedure to extract and isolate, as well as purify and
identify the compounds which can be very complex molecules. To determine and isolate
such compounds from the medicinal plant, it is important to understand its physical and
chemical properties. The target may be a major compound that is easily found and isolated;
otherwise an advanced purification method should be developed when the compound is
difficult to separate. Using a classical method like column chromatography is not always
satisfactory due to the possibility of column blockage with particulates from the crude
sample, column properties changing with time and the expense of replacing the column
material. There will be occasions when an alternative and efficient method therefore needs
to be developed, and liquid flow processing known as counter-current chromatography
(CCC) seems to be suitable for this purpose. CCC is an excellent alternative to avoid the
problems associated with solid-phase adsorbents and to preserve the chemical integrity of
mixtures subjected to fractionation. Furthermore, the advancing technology of CCC is easy
and predictable to be scaled up (Doshi, 2010; Sutherland, 2009).
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1.1.3 The preparation of α-mangostin as a standard using CCC
To develop an efficient method for the production of α-mangostin, the study
described in this thesis was undertaken to develop a one step isolation and purification
process of to obtain α-mangostin as a standard material from fruit rinds of Garcinia
mangostana L., using liquid flow processing (CCC). Importantly, the method developed is
different from existing methods that have previously been performed. This research was
undertaken initially on an analytical scale CCC instrument (17.4 mL coil; 0.8 mm bore)
using Mini High Performance Counter Current Chromatography (HPCCC) and an aqueous
ethanol extract of mangosteen fruit rinds as a sample. The sample was prepared by
overnight maceration of mangosteen rinds powder in 80% aqueous ethanol at 30⁰C. To
produce a high throughput of α-mangostin, the method was developed and optimised by
increasing volume and concentration of sample with multiple injections up to 10 times
without any replacement or topping up the stationary phase. The developed method was
then scaled up on semi preparative Spectrum HPCCC instrument (143.5mL coil; 1.6 mm
bore) and on preparative Midi HPCCC instrument (912.5 mL coil; 4 mm bore). Using this
method has some advantages such as simpler; reduce cycle time and less solvent use.
Moreover, using this method provided α-mangostin with high purity, yield and recovery as
well as throughput.
1.2 LITERATURE REVIEW
1.2.1 Mangosteen and mangostin
Among tropical fruits, Garcinia mangostana L (mangosteen) is the most popular
and valued in the family Clusiaceae (Morton, 1987). The origin of the mangosteen is not
exactly known, but it is believed to come from the Sunda Islands and the Moluccas of
Indonesia. The mangosteen tree can be described as a slow-growing tree, erect with a
pyramidal crown; and attains 20 to 82 ft (6-25 m) in height. The fruit, capped by the top
calyx at the stem end and with 4 to 8 triangular, flat remnants of the stigma in a rosette at
the apex, is round, dark-purple to red-purple and smooth externally; 1 1/3 to 3 in (3.4-7.5
cm) in diameter. The rind is 1/4 to 3/8 in (6-10 mm) thick, red in cross-section, purplish-
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white on the inside. The flesh is juicy, slightly acid in flavour and delicious (Morton, 1987).
Mangosteen fruit can be obtained as fresh fruit, packed in cans, or made into syrup/juice.

Figure 1.1 Mangosteen fruits
Mangosteen thrives in most of Southeast Asia countries such as Indonesia,
Thailand, Malaysia and Myanmar which have tropical climates in the whole year. People in
those countries, especially in Thailand, have traditional used the hull of mangosteen as a
medicine for skin infection, wounds, and diarrhoea for many years. In Indonesia, it is
traditionally used for treating haemorrhoid, thrush and wounds as well. The rinds of the
fruit are used as a natural dye for textiles and the trunk is used as building materials, and for
firewood/crafts (Obolskiy, 2009).
Reviews of mangosteen have been carried out especially in the area of
phytochemical and pharmacological effect, other traditionally applications, including the
therapy of various diseases such as dysentery, urinary disorders, cystitis and gonorrhoea
(Obolskiy, 2009). Currently, some new interesting properties are being reported and
research on the mangosteen area has been growing rapidly, not only in Asian countries
where mangosteen originates but also in USA and European countries. It has been reported
that phytochemical and pharmacological studies on xanthone and their derivatives isolated
from the mangosteen fruit rind are the most widely performed to explore the benefit
properties and efficacy of mangosteen as the queen of tropical fruit. Nevertheless, the
research on toxicity is still very limited and preliminary toxicity studies need to be
improved to ensure safety in the use of Mangosteen products (Ajayi, 2007).
It has been reported that a 40% ethanol extract of mangosteen hull could inhibit
both histamine release and prostaglandin E2 synthesis (Nakatani, 2002). This suggests that
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the crude extract is promising for both anti allergy and anti inflammatory agent. Other
researchers have claimed that the crude methanol extract from the pericarp of Garcinia
mangostana had anti-proliferative, apoptotic and antioxidative properties, so it has the
potential as a natural cancer chemoprevention agent (Moongkarndi, 2004). Furthermore the
crude ethanol extract showed α-glucosidase inhibitory activity and elicited a reduction of
postprandial blood glucose levels that is a potential for anti-diabetes (Ryu, 2011). In vitro
cytotoxicity studies of lyophilized hot water and juice extract of the fruit rind of
mangosteen against K562, P3HR1, Raji, and U937 leukemic cells have exhibited a potent
anti-leukemic activity for the hot water extract (Chianga, 2004).
The latest in scientific research confirms that mangosteen contains a class of
naturally occurring polyphenolic compounds known as xanthones. Isolation and
identification of xanthones and their derivatives: α-mangostin, 8-desoxygartanin, gartanin,
β-mangostin, 3-mangostin, and 9-hydroxycalabaxanthone has been reported (Walker,
2007). The results of several research projects show that xanthone has properties which
include antioxidant activities (Suvarnacuta, 2011; Zarena and Sankar, 2009 a, b; Zarena and
Sankar, 2012), analgesic and anti-inflammatory (Cui, 2010), anti cancer therapeutics
(Tangpong, 2011), and Alzheimer’s disease (Moongkarndi, 2010). Many scientists have
reviewed the medicinal properties of Garcinia mangostana L. extract for antioxidant,
antitumor, anti allergic, anti-inflammatory, antibacterial and antiviral activities (Caverri,
2008; Dembitsky, 2011; Kapoor, 2009). It has even been mentioned by other reviewers that
mangosteen xanthones are effective for treating gastrointestinal disturbances and for
wound-healing including antifungal, anti malarial, and anti-HIV (Kinghorn, 2011). This
seems to suggest a potential for development as an anti-virus medicine in the future,
especially for anti HIV-AIDS virus which no effective treatment is currently available.
The most medicinally important xanthones isolated from mangosteen are
α-mangostin and γ-mangostin. Mangostin with molecular formula: C24H26O6; Mol. Wt. =
410.46, is a natural organic compound isolated from the mangosteen plant. It is a yellow
colour, crystalline solid with a xanthone core structure (The Merck Index, 13th edition
2001). This mangostin has density of 1.265 g/cm3; melting point of 180-182 ºC, boiling
point of 640.1 ºC at 760 mmHg and flash point of 220.3 ºC. It is a specific chemical
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compound in mangosteen so it can be used as a marker for the analysis of mangosteen. The
chemical structures of α, β, and γ-mangostin are as follows:

Figure 1.2 Chemical Structures of Mangostins (Pothitirat and Gritsanapan, 2008)
Alpha-mangostin: R1 = CH3, R2 = R3 = H
Beta-mangostin: R1 = R3 = CH3, R2 = H
Gamma-mangostin: R1 = R2 = R3 = H
Mangostin has been shown to have an analgesic and anti-inflammatory effect (Cui,
2010; Chena, 2008), antioxidant and neuroprotective effect (Chaverri, 2009; Chin, 2008;
Abundis, 2010), cytoprotective effect (Sampath and Vijayaragavan, 2008), anti-acne
producing bacteria (Pothitirat, 2009), anti-melanoma agents (Wang, 2011), abscess and skin
infection (Tewtrakul, 2009), inflammation, pain and neuropsychiatric symptoms effects
(Sukma, 2011), moderate inhibitory effects on cAMP phosphodiesterase (Chairungsrilerd,
1996), Alzheimer’s disease (Moongkarndi, 2010), potent inhibitory activity of
prostaglandin E2 (Nakatani, 2002), renoprotective effect against cisplatin-induced renal
damage in rats (Pérez, 2010), preventive and therapeutic application for cancer treatment
(Matsumoto, 2004), reduced [Ca2+] elevation by suppressed Ca2+ influx/ Inhibitory effect
on rat basophilic leukaemia RBL-2H3 cell de-granulation (Itoh, 2008), in vitro cytotoxicity
against human colon cancer DLD-1 cells and effective chemo-sensitizer (Nakagawa, 2007),
and

significant

anti-mycobacterial

activity

against

Mycobacterium

tuberculosis

(Arunrattiyakorn, 2011). Recent investigations of the anti tuberculosis potential of
mangosteen revealed that tovophyllin B possesses a significant inhibitory activity against
Mycobacterium tuberculosis (MIC = 25 lg/mL). Direct synthesis of α-mangostin has been
established by researchers from Japan (Iikubo, 2009). After assessment they concluded that
the α-mangostin was a potent inhibitor against the acidic sphingomyelinase cause of death
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in early childhood. Mangosteen can also enhance the clinical effect of periodontal treatment
(Rassameemasmaunga, 2008) and shows excellent apoptotic effects on head and neck
squamous cell carcinoma (Kaomongkolgit, 2011). It can potentially be developed as a new
medicine for anti-inflammatory and anti cancer.
On the other hand research on mangosteen, especially on pericarp or shells, has
grown not only for pharmacological investigation but also for cosmetic application as
ageing control, anti-acne and natural dye (Pothitirat, 2009; Zhou, 2011). Mangostin shell
was effective in removing low concentrations of toxic metal such as lead, zinc and cobalt,
so it might be useful for water purification or other related purposes (Zein, 2010). Since
mangosteen has been shown to have strong antioxidant activity, research on mangosteen
has developed in the area of nutraceutical and food additive, so that xanthones from
mangosteen are claimed as phytonutrients, natural antioxidant, and food preservative
(Kapoor, 2009; Dembitsky, 2011; Zhou, 2011). In addition, pelargonidin 3-glucoside that is
contained in mangosteen was also investigated to be a natural colorant in food and use of
this new natural colorant has increased (Zarena, 2012). Moreover, a group of Indian
researchers have reported that the leaf extract of mangosteen can be used as a reducing
agent when doing biologically synthesised nanoparticles that are highly effective against
different multi-drug resistant human pathogens (Veerasamy, 2011).
Because of the widely varied potential benefits of Mangosteen and its derivatives
for drug, traditional medicine, food supplement, cosmetic and food additives, it can be
estimated that in future there will be more mangosteen products produced and offered by
pharmaceutical and food supplement industries to meet market needs.
1.2.2 Isolation of mangostin
Separation and isolation of α-mangostin and other xanthones from mangosteen have
been performed by different researchers in several ways in order to obtain the maximum
amount of Component. However, they generally used maceration at room temperature with
a wide variety of organic solvents such as methanol, ethanol, butanol, ethyl acetate,
chloroform, hexane, and ethyl chloride for extraction and isolation; and used column
chromatography for fractionation as well as purification. A α-mangostin isolation
processing was developed and patented in the USA by Boehringer Ingelheim Pharma
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Company in January 2006 using several steps with various aqueous alcohol and aromatic
solvent of 1.2-ethanediol and toluene in preferable temperature range 60-80⁰C. The crude
product was purified in a Kühni column and using this method, the quantity of α-mangostin
extracted was 2.48% of the crude in the toluene extract (Sobotta, et. al., 2006).
An isolation method by Marquez-Valadez et al. (2009), repeated by Caverri (2009),
used silica gel column chromatography eluted with hexane/CH2Cl2 (from 4:6 to 0.1) after
macerating by CH2Cl2-MeOH (1:1). The amount of α-mangostin was 3.15% (Caverri,
2009). An extraction method has also been performed by Rahmania, in Research Center for
Drug and Food of NADFC-RI (personal communication) which gave 1.66% of αmangostin. The method employed macerating the crude mangosteen rinds powder in 80%
ethanol in water at room temperature for 24 h with occasionally stirring. The maceration
was repeated until colourless solvent was obtained and the macerates were pooled. The
solvent was removed by rotary evaporator to yield a concentrated extract. The ethanol
extract was then dissolved in 50% methanol in water and partitioned 3-4 times in a
separating funnel using n-hexane for 15 min each to remove non polar compounds. The nhexane phase was removed from the funnel and ethyl acetate added to the methanol-water
phase and shaken. The addition of ethyl acetate was repeated 3-4 times until the layer of
ethyl acetate was colourless. The ethyl acetate phase was collected and dried down using a
rotary evaporator and then fractionated by column chromatography with silica gel 60 as the
stationary phase and eluting with a number of n-hexane-ethyl acetate mixtures which had
different concentration of n-hexane from 10% to 90%. There were 31 fractions divided into
6 combined fractions which had the same TLC profile from the eluent of n-hexane/ethyl
acetate (8:2 v/v). Fractions with the same TLC profile were combined and the solvent was
removed using a rotary evaporator at 40-50⁰C. The extract was crystallized and recrystallised using methanol and n-hexane. The crystals were analysed by TLC. From the
TLC analysis, 2 spots were observed therefore the crystal was purified further using
Sepacore apparatus (an isocratic flash chromatography technique) with n-hexane/ethyl
acetate (8:2 v/v) as a mobile phase and analysed again by TLC. The fraction which had
only one spot on TLC was assumed as pure mangostin. The melting point was measured
and the sample identified by UV-Vis Spectrophotometer, Fourier Transform Infrared
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Spectroscopy (FTIR) and Nuclear Magnetic Resonance Spectroscopy (NMR) (Rahmania,
2009).
Ee et al. (2006), a group of researchers from Malaysia, have isolated and identified
α-mangostin, β-mangostin and other xanthones from the finely ground stem bark of
Garcinia mangostana L. They obtained 0.007% of α-mangostin and 0.005% of βmangostin in the n-hexane extract of 1.5 kg mangosteen crude after purifying by column
chromatography using hexane, hexane/dichloromethane, dichloromethane/ ethyl acetate
and dichloromethane/methanol as the eluting solvents. The compounds were determined by
spectroscopic methods such as 1H NMR,
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C NMR, and mass spectrometry (MS) (Ee,

2006).
1.2.3 Counter-current Chromatography
1.2.3.1 Distribution in two- Phase Systems
Counter-current chromatography (CCC) is a modern technology that is suitable to
separate individual chemical compounds, or groups of compounds from complex mixtures.
Therefore it is becoming widely used as a versatile method of purifying a variety of
materials (Doshi, 2010; Sutherland, 2000). CCC is defined as a liquid chromatography
(LC) technique that uses two immiscible liquid phases without any solid support (Berthod,
2009).
Conventional liquid chromatography employes a single phase to elute the analytes
released from the adsorptive or liquid phase coated solid support. On the other hand, the
CCC technique uses a two-phase solvent system made of a pair of mutually immiscible
solvents, one used as the stationary phase and the other as the mobile phase. The use of
two-phase solvent systems allows one to choose solvents from an enormous number of
possible combinations (Ito, 2005). One major advantage of working with a liquid as
opposed to a solid stationary phase is that the solutes have access to the whole volume of
the stationary phase (Berthod, 2007).
A unique advantage of CCC is the ability to change the elution mode by simply
selecting which of the two liquid phases is the mobile phase, effectively selecting either
normal or reverse phase mode of elution. Scaling up CCC is also simple because CCC is
mathematically linear and very predictable. The major challenge of CCC is to obtain a
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stable support-free liquid stationary phase (Berthod, 2009). Migration through the column
is controlled by the partition coefficient also known as the distribution ratio (KD) (Conway,
1995).
The distribution ratio is a concentration ratio between compounds dissolved in the
stationary phase divided by compounds dissolved in the mobile phase. A compound with
KD= 0 will not dissolve in the stationary phase and will come out with the solvent front in a
time dictated by the volume of mobile phase. A compound with KD= 1 will be equally
soluble in both phases and therefore elute with the column volume in a time dictated by the
column volume divided by the flow rate. This effect is measured by the following formula:

KD =

CS
CM

CS is the concentration of a sample component dissolved in the stationary phase (SP) and
CM is the concentration of the same component dissolved in the mobile phase (MP). Good
KD values are between 0.5 and 2, if KD<0.5 there will be loss of peak resolution. Otherwise,
if KD>2, long retention time and peak broadening will occur (Doshi, 2010).
Component elution of sample on CCC can be illustrated in the diagram below:

Figure 1.3 Diagram of Component Elution on CCC (Anon6)
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The diagram shows the theoretical elution of a compound with a partition
coefficient/distribution ratio (KD). The liquid–liquid partition ratio of the solute in the
biphasic liquid system used to perform the CCC separation is the only parameter in the
retention equation

VR = VM + K DVS
Where VM is the mobile phase volume and VS is the stationary phase volume inside the
CCC apparatus. VM corresponds to the hold-up volume in HPLC (Berthod, 2009). Since
there is no solid support, the column volume (VC) is calculated according to equation
below:

VC = VM + VS
To calculate the peak elution time (retention time) for any of Components is used
the following equation:

tR =

VC
1 + S f (K D − 1)
F

[

]

Where VC is the column volume, F is the MP flow rate, Sf is the SP retention and KD is the
distribution ratio. Running CCC with the same conditions will provide the same retention
time of the target peak. Once the system is developed, prediction of elution times is easy
(Conway, 1995).
On CCC running where two liquid-liquid phase systems are used, the column is
simply filled with the stationary phase (SP) by pumping at a high flow rate without rotation
until at least one complete coil volume. The mobile phase is pumped at the chosen flow rate
with column rotation at the desired speed. The displaced volume of SP is measured using a
graduated cylinder. When the displacement of SP ceases, the column has reached a state
called hydrodynamic equilibrium and the column is ready for injection. Since the
displacement volume and the column volume are known, the amount of stationary phase
left in the column can be calculated and predicted exactly. The compounds will elute based
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on their distribution ratio (partition coefficient). The stationary phase retention factor (Sf) is
calculated using the following formula:

%S f =

VC − VDISP
× 100
VC

Where VC is the known column/coil volume and VDISP is the displaced volume of SP in a
graduated cylinder. Larger retained stationary phase (Sf ) values mean that the column
capacity available for the separation is greater and resolution is enhanced. There are mainly
two different ways to obtain a liquid stationary phase, using centrifugal forces, the
hydrostatic way and the hydrodynamic way (Berthod, 2009).
In separations by chromatography, resolution is directly influenced by the ratio of
SP volume (VSP) and MP volume (VMP) i.e. the higher the ratio, the better the resolution
will be.

RS ∝

VSP
VMP

The efficiency of the separation can be expressed in terms of peak resolution (Rs) using a
conventional equation,

RS =
Where V,

2(VRA − VRB ) 2[(tr ) A − (tr ) B ]
or
(WA + WB )
WA + WB

t and W indicate the retention volume, retention time and the peak width of the

specified peaks, respectively (Ito and Yu, 2009). VRA is retention volume of the earlier and
VRB is retention volume of the later eluted peaks. WA and WB are their respective base
widths. The resolution of adjacent peaks is also given by:

RS =

2 ∆Z
WA + WB
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Where ∆Z is the separation between peaks A and B; and WA and WB are the widths at the
base of peaks A and B, respectively.
Acceptable resolution is on the order of RS = 1.0, and baseline resolution between
two peaks (as shown in the figure below) requires an RS > 1.5

Figure 1.4 Chromatographic resolutions
Berthod et al demonstrated very well in the chromatograms of the figure below that
chromatographic resolution declines dramatically as SF decreases:

Figure 1.5 Correlation between retention volume of stationary phase (Sf) and
chromatographic resolution on CCC (Berthod, 2009)
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Comparison of chromatograms on Figure 1.5 obtained with the same hydrodynamic
CCC column, the same biphasic liquid system, and the same sample containing 10
compounds. The volume of stationary phase retained decreased from 108 mL (SF = 90 %)
to 36 mL (SF = 30 %). Column volume VC = 120 mL (vertical dotted line), average
efficiency 500 plates (Berthod, 2009).
1.2.3.2 Hydrostatic (CPC)

Centrifugal Partition Chromatographs (CPC) was first introduced in 1982. Its early
use focused on determining octanol–water partition coefficients, the separation of natural
products and the extraction of heavy metals. In 1990, Foucault and Nakanishi published a
comparison of several aqueous two-phase systems for the fractionation of biopolymers
using CPC (Sutherland, 2008).
There are two column types that can be used to retain a liquid stationary phase, the
hydrostatic and the hydrodynamic designs. Classical hydrostatic is referred to droplet CCC
columns which have a single rotational axis and use only gravity to maintain the liquid
stationary phase, it takes very long elution times (days). Because of the efficiency reason,
the droplet CCC column is no longer in use today. Modern hydrostatic is referred to CPC
(Berthod, 2009). The performance of this CPC equipment far exceeds the original gravity
stabilised Droplet Counter-current Chromatography (DCCC) due to using centrifugal force
(circa 200g) but the construction mimics DCCC and this design concept does have flaws.
CPC machines rotate around only one axis.
CPC is composed of a number of partition channels which are linked in cascade by
ducts. The single-axis centrifuge generates centrifugal force to retain stationary phase while
the mobile phases are passing. Mixing and settling take place in individual partition cells
that compose a group of partition disks (Yoon, 2010). CPC is actually a continuous form of
counter-current distribution where a series of chambers are fitted circumferentially on a
disc which is rotated to create a centrifugal force field. Each chamber has a connection
from the top of one to the bottom of the next. The chambers are initially filled with the
stationary phase and then the mobile phase is pumped through displacing some of the
stationary phase and creating a series of chambers with a retained volume of stationary
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phase and cascade mixing much like a waterfall between the mobile phase and the retained
stationary phase in each chamber (Sutherland, 2008).
As mentioned above, CPC is basically hydrostatic like Droplet CCC however; there
are improvments in mixing and more theoretical plates with rotor spinning and one axis of
gyration, using centrifugal field to hold a better stationary phase retained than in
gravitational field, has constant g-field and also provides much faster separations than in
DCCC (Murayama, 1982).
The hydrostatic CCC column can be described as a schematic of CPC below,

Figure 1.6 Schematic of CPC as a basic of Centrifugal Partition Chromatography
(Doshi, 2009)
The schematic reflects the liquid motion in hydrostatic CCC columns in centrifugal
partition chromatographs. CPC use centrifugal force to speed separation and achieves
higher flow rates than DCCC (which relies on gravity). CPC can be operated in either
descending or ascending mode, where the direction is relative to the force generated by the
rotor rather than gravity. According to the fast and permanent evolution of the cells design,
the efficiency and flow rate with low back pressure are improved (Doshi, 2009). There is a
single axis of rotation producing constant centrifugal field and no phase exchanges in the
connecting ducts. This design reduces the contact time for solute exchange with the
stationary phase. It also builds a hydrostatic pressure that explains the significant pressure
drop needed to operate hydrostatic centrifuges. All hydrostatic centrifuges contain two
rotary seals; one at the top and the other one at the bottom. They are quiet to operate. CPC
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instruments are generally operated at higher flow rates and higher back pressures (Berthod,
2009).
Helix CCC or toroidal coil CCC system is usually run under a centrifugal force. The
dimensions of the coil are condensed to a design which is convenient for analytical
separations. The coil is fitted around the periphery of the centrifugal bowl so that the
radially acting centrifugal force field retains the stationary phase in one side of the coil, as
in the basic hydrostatic system described above.
Ito and Yu have introduced a new configuration of the toroidal coil using an
equilateral triangular core, which improves both retention of the stationary phase and peak
resolution. The performance of this triangular helical tube has been demonstrated on the
CCC separation of dipeptide samples with a two-phase solvent system composed of 1butanol-acetic acid-water at a volume ratio of 4:1:5, using a rotary-seal-free continuous
flow centrifuge system (Ito, 2009).
1.2.3.3 Hydrodynamic

A hydrodynamic design column has a variable and cyclic centrifugal field produced
by the planetary rotation of the bobbin around its own axis and the central rotor axis. There
is contact between the two liquid phases throughout the tubing. In the schematic below, the
mobile phase is pictured in black and the stationary phase is white (Berthod, 2009).

Figure 1.7 Schematic view of hydrodynamic design on the liquid motion in CCC
(Berthod, 2009)
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In a hydrodynamic column, there is a variable and cyclic centrifugal field produced
by the planetary rotation of the bobbin around its own axis and the central rotor axis.
(Berthod, 2009).
The hydrodynamic centrifuges used in the CCC columns have two rotational axes, a
main axis and a planetary one which generates a variable centrifugal force field. There can
be any number of planetary axes but the most common are single, double, and triple axes.
Each planetary axis has a bobbin or spool mounted on it that contains the coils of
continuously wound metal or plastics tubing. In hydrodynamic columns, it is important to
know the ratio of the spool radius, r, over the rotor radius, R. This ratio was traditionally
termed β. Since β is defined in LC as the phase ratio VS/VM so the CCC beta ratio should
be noted β = r/R.

Figure 1.8 Schematic illustration of the type-J synchronous planetary motion of a
multilayer coil separation column (Ito, 2005)
These machines have a continuous length of tubing, the column helically wound on
a bobbin that rotates on its own axis and which itself rotates around a central axis to
achieve a planetary motion. This motion sets up an oscillating hydrodynamic force field,
which causes a mixing and settling step to occur with each revolution of the bobbin. This
hydrodynamic force field also leads phases of differing density to travel to opposite ends of
the coil; this phenomenon alone retains the SP. The benefit of this design is it operates at
low pressure, which allows higher mobile phase flow rates and hence shorter separation
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times. This apparatus has been developed to High Performance Counter Current
Chromatography (HPCCC) which produces relatively high stationary phase retention
across the complete range of biphasic systems used so there is reduced cycle time and
hence increased throughput (Ito, 2005).
A simply installation of HPCCC can be figured as a schematic diagram as follows:

Figure 1.9 Schematic layout of a typical CCC set-up (Garrard, 2005)
The schematic diagram represents a simple installation of HPCCC unit. The HPCCC is just
a different type of column, replacing the solid stationary phase (SP) column of HPLC or
Flash. The primary alteration to the system is the fitting of a restrictor downstream of the
pumps, if the pumps currently operate at high pressures, HPCCC works at significantly
lower pressures than HPLC. Performing scale-up of purification between differing capacity
HPCCC instruments is quick and simple. HPCCC instruments create the same operating
conditions so simply using the volumetric ratio between the two column volumes can
determine the new sample volume and mobile phase flow rate. A further significant
advantage concerns sample solubility. Often a limiting factor with HPLC purifications,
with HPCCC instruments particulates sample can be injected onto the column in either
mobile, stationary or a mixture of both phases, without affecting the performance of the
chromatography.
Counter-current chromatography benefits from a number of advantages when
compared to the more traditional liquid-solid separation methods i.e. (i) no irreversible
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adsorption; (ii) total recovery of injected sample; (iii) low risk of sample denaturation, (iv)
simpler with fewer steps of purification process (Marston and Hostettmann, 2006).
In addition, there are several other strengths which researchers consider for CCC,
such as CCC can cope with a wide range of radically different polarity compounds; allows
particulates and extract solid samples; achieves > 99 % purity of Components from
complex samples; takes extremely complex matrices, such as natural product extracts and
heart cut target polarities, bio-actives etc without risk of on-column degradation or
adsorption; uses exactly the same type of liquid pumps, injectors, switching valves fraction
collectors etc as HPLC or flash chromatography; scale up is linear and predictable etc.
(Doshi, 2010).
1.2.3.4 Use for natural products

Nowadays, research on natural products is rapidly growing, especially on isolation
and purification of the active compounds from medicinal plants which will be developed as
new natural medicines. Regarding these purposes, CCC has become a choice method and
has made possible the separation of a number of biologically interesting natural products
that are difficult or impossible to separate by other techniques. Crude extracts of plants or
other organisms are often too complex for the direct analysis by HPLC. Certain materials
may irreversibly bind to the packing material or may plug the column inlet filters, and
hence reduce the column life. Those restrictions do not apply to analytical CCC, which
represents an interesting method for enrichment and separation of various analytes
(Berthod, 2009).
Applications of CCC in analytical chemistry and comparison with other separation
and enrichment methods have shown that the techniques can be successfully used in the
purification of plants and other natural products including fermentation. It is almost
universally applicable on mg scale to multi-gram scale as a preparative purification
technique for both polar and non polar organic materials as well as inorganic mixtures such
as rare earths. It has been applied to many classes of compounds, including agricultural
chemicals, alkaloids, amino acids, peptides, proteins, antibiotics, drug metabolites, dyes,
food products, flavonoids, glycosides, herbicides, pesticides, pharmaceuticals, optical
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isomers, saponins, tannins, metals and other inorganic materials. (Berthod, 2009; Conway,
1995).
Different types of hydrodynamic (High Speed CCC, cross-axis coil) and hydrostatic
(toroidal coil) centrifuges can be used for separation and concentration of various
compounds from plant and different natural products. The quantity of separated compounds
may range from trace to gram amounts (Berthod, 2009).
Currently the reasons for increasing application of CCC in the separation of natural
products include:
1. Bioactive natural products are frequently found in very small amounts and may
be lost due to irreversible adsorption in conventional column chromatography.
2. CCC can enable savings in solvent consumption costs and once optimal
separation conditions are selected for Components by a reduction in the total
number of separation steps required (Yoon, 2010).
The new legislation on traditional herbal medicinal products in China requires them
to be designated as medicines rather than functional foods. A recent review of the role of
counter-current chromatography in the modernisation of Chinese herbal medicines clearly
shows that the use of the CCC technology is growing in China, particularly for isolation
and purification of natural products including group of flavonoids, alkaloids, polyphenol,
terpenoid, coumarins etc. (Figure 1.10) (Sutherland, 2009).

Figure 1.10 Pie chart showing the classification of the 363 different compounds
isolated in the modernisation of Chinese herbal medicines (Sutherland, 2009).
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In purification of Chinese Herbal Medicines, alkane/alcohol systems are now by far
the most popular representing nearly 40% of the phase systems used. The usage has
changed over time. Prior to the year 2000, chlorinated systems were used twice as
frequently as alkane systems. The decrease in use recently reflects the need to avoid such
solvents on health and safety grounds. By 2007 alkane systems were used in 70% of the
papers. More recently, papers have been appearing which use acetonitrile systems and
acetic acid systems (Sutherland, 2009). Probably the two most commonly used solvent
systems in the area of natural products for aqueous-organic phase system have been ternary
chloroform/methanol/water and the quaternary hexane/ethyl acetate/methanol/water
systems (Conway, 1995).
1.2.3.5. Use for Proteins and Large Molecules
CCC has been employed for performing purification of biological samples
including protein and larger structures, based on partitioning technique using aqueous–
aqueous polymer phase systems. The most common solvents used in this technique are
polyethylene glycol (PEG)–dextran and PEG–potassium phosphate systems. This
partitioning of biological macromolecules was first established by Albertsson in the 1950s
(Shibusawa, 2006). Currently in modern biotechnology, the technique is growing interest
not only for downstream processing of enzymes but also in efficient methods for the large
scale recovery and purification of fermentation products, such as intracellular enzymes and
biologically active proteins which require low to medium purity but the absence of
interfering activities for industrial catalysts; and the other is required high purity for
analytical and medical applications (Hustedt, 1985).
When aqueous two-phase systems (ATPSs) and liquid–liquid partition-based
counter-current chromatography (CCC) are employed for the separation of large bioactive
molecules including proteins, DNAs and RNAs, it can avoid risks of sample loss,
denaturation, and greatly reduce processing time. Biologically active large molecules, such
as commercially important or potentially important therapeutic proteins, DNAs and RNAs,
need to be prepared under benign physiochemical milieu to preserve their biological
activities. There are at least two important factors affecting the maintenance of their
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bioactivities: the media used for separating and purifying the required large molecules and
the processing time for exposing these molecules in such media (Guan, 2010).
Some researchers have developed a new method for the separation of proteins using
liquid-liquid partition using CCC. It has been reported that the cross-axis coil planet
centrifuge (X-axis CPC) is useful for partitioning macromolecules with aqueous–aqueous
polymer phase systems. Performance of the apparatus was evaluated on protein separation
using an aqueous–aqueous polymer phase system composed of PEG 1000 and dibasic
potassium phosphate with four multilayer coiled columns. This apparatus would be useful
for the separation of various bioactive compounds with polymer phase systems (Shinomiya,
2006)
Study on the separation of a protein mixture containing of myoglobin, cytochrome
c, and lysozyme has been done by HSCCC using a two-phase aqueous/reverse micelle-

consisting organic solvent system. Both pH and potassium chloride (KCl) concentration
gradients were applied in the separations. In addition to efficiency of separation,
enrichment of protein was also examined at the same time. The study confirmed the
feasibility of performing protein separation and enrichment in one chromatographic run in
HSCCC. (Shen and Yu, 2007).
A review on the recent progress of protein and larger molecules separation in the
industrial scale-up using liquid-liquid chromatography technique was done by Sutherland.
This review considers recent developments in centrifugal liquid-liquid partition
chromatography using aqueous two-phase solvent systems, a gentle host medium for
biologicals, and the prospect for scale-up and eventual manufacture of high-value
pharmaceutical products. With the results demonstrated in various machines from different
manufacturer, the author has highlighted particularly the efficiency of each instrument
when used in separation i.e. lysozyme and myoglobin. This case illustrates the important
role of CCC in the use of drug and health supplement development (Sutherland, 2007).
1.2.4 Counter-current Chromatography and Mangostin
The major xanthones (α- and γ-mangostins) in mangosteen fruit pericarp (MFP)
have recently been reported to be isolated at high purity in one step using high-performance
centrifugal partition chromatography with a solvent system containing petroleum ether/
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ethyl acetate/methanol/water (10:5:5:1).From a load of 200 mg crude extract of MFP 55.4
mg α-mangostin with 93.6% purity and 12.4 mg γ-mangostin with 98.4% purity were
obtained, with yield of 86.3% and 76.3%, respectively. The xanthones were characterized
by comparing the retention time and UV spectrum with commercially available standards
(Shan, 2010).
Screening and fractionation method for major xanthones in pericarp of Garcinia
mangostana has been developed using CPC directly interfaced with mass spectrometry.

Extraction was done by pressurised liquid extraction with ethanol and separated at the semipreparative scale by centrifugal partition chromatography (CPC) with a biphasic solvent
system composed of heptane/ethyl acetate/methanol/water (2:1:2:1, v/v/v/v). Separation
and identification of the compounds were applied by CPC-electro-spray ionisation MS
coupling. An additional stream of ethanol/1 mol L−1 ammonium acetate (95:5, v/v) and a
variable flow splitter were also included, and all the compounds in the solvents used in
mobile phase for the CPC separation were analysed. The dual mode or elution–extrusion,
which is less solvent-consuming and faster than the elution mode, was used without loss of
ionisation and detection (Destandau, 2009; Yoon, 2010).
A method for extraction of α-mangostin and γ-mangostin from Garcinia
mangostana was developed as a microwave-assisted extraction (MAE) by Fang, et al. The

experiment conditions were optimised using orthogonal test and 5 g sample was extracted
with the optimised conditions. Isolation and purification was performed by high-speed
counter-current chromatography (HSCCC) with a two-phase solvent system consisting of
petroleum ether/ethyl acetate/methanol/water (0.8:0.8:1:0.6, v/v) and resulting 75 mg of αmangostin at 98.5% purity, and 16 mg of γ-mangostin at 98.1% purity from 360 mg crude
extract of G. mangostana in less than 7 h. The purity of the two xanthones was identified by
HPLC. Their structures were further characterised by ESI-MS, 1H NMR and

13

C NMR

(Fang, 2011).
Isolation and purification of major xanthones in another medicinal plant (Swertia
mussotii) have also been performed on HSCCC using solvent system containing n-

hexane/ethyl acetate/methanol/water (5:5:10:4, v/v/v/v). The experiment conditions were
reverse phase running at flow rate of 1.5 mL/min, a rotation speed of 800 rpm and a
temperature of 25⁰C. Using the described method, a 150 mg crude sample yielded 8mg of
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methylswertianin, 21mg of swerchirin and 11mg of decussatin with purities of over 98%.
The compounds isolated were determined by 1H-NMR and 13 C-NMR analyses (Jia,
2011).
1.2.5 High Performance Liquid Chromatography
1.2.5.1 Principle and Theory
Many scientists are very familiar with High Performance Liquid Chromatography
(HPLC). This instrument is applicable for a wide range purposes; not only for chemical,
pharmaceutical, cosmetics and food industry but also in agriculture, environment, mining
and many other purposes including biomedical as well as veterinary, where the sample is
blood and other biological fluids (Levin, 2001). In drug clinical trials, HPLC plays an
important role for the determination of bioavailability and metabolite level of a drug in the
human body. It is also important in forensic science to analyse an unknown sample
obtained from a crime scene or victim. In phytochemical studies, chromatography is
commonly used, particularly for fingerprinting analysis, extraction, isolation, purification
and analysis of Components in medicinal plants or natural resources.
Chromatography was invented by a Russian botanist, Mikhail Tswett around 1906
when he separated pigments of a plant by organic solvent as a mobile phase and chalk as a
stationary phase. In 1941, Martin and Synge developed liquid-liquid partition
chromatography which led them to winning a Chemistry Nobel Prize in 1952 (Harris,
2005). The chromatography word comes from “chromos” meaning colour and “graphos”
meaning writing, therefore literally “colour writing”. Now, it is considerably more
sophisticated, however there are still some basic principles that must be applied for
successful operation of a chromatography system.
Chromatography is a physical method of separation in which the components to be
separated are distributed between two phases, one of which is stationary (stationary phase)
while the other (the mobile phase) moves in a definite direction (Eti're, 1993). There are
many different types of chromatography depending on the mobile and the stationary
phases. Chromatography which uses liquid as the mobile phase is called liquid
chromatography (LC) and gas chromatography (GC) is chromatography where gas is used
as the mobile phase. According to the stationary phase, liquid chromatography is divided
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into several types such as HPLC, Flash Chromatography (FC) and Supercritical Fluid
Chromatography (SFC) when the stationary phase is a solid. On the other hand, Counter
Current Chromatography (CCC) and Centrifugal Partition Chromatography (SPC) are the
types of liquid-liquid chromatography. In addition, there are two types of GC i.e. Packed
Column Gas Chromatography with a solid as a stationary phase and Gas Chromatography
with liquid as a stationary phase.
In general, liquid chromatography can be defined as an analytical chromatographic
technique that is useful for separating ions or molecules dissolved in a solvent. The sample
is poured onto the top of the column followed by the solvent system. LC separation
mechanism is due to differences in adsorption, ion exchange, partition, or size. If the
sample solution is in contact with the solid or liquid stationary phase, the different solutes
will interact with the other phase with different degrees and allow the mixture components
to be separated from each other and determine the transit time of the solute through the
column. Sometimes the column contains active solids (adsorption), ionic groups on a resin
(ion-exchange), liquids on an inert solid support (partitioning), or porous inert particles
(size-exclusion). The compounds are separated by accommodating the solution from the
column effluent with the time (Tissue, 2000). The schematic can be seen in Figure 1.11.

Figure 1.11 Schematic of a simple liquid chromatographic separation (Tissue, 2000)
Chromatography can be preparative or analytical. The aim of preparative
chromatography is to isolate as much as possible of the desired component from a complex
sample mixture. It can also serve to separate the components of a mixture for further use
and to purify large scale of products. Furthermore, it is also used in ultra trace separations
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where disposable columns are used once. Conventional LC is most commonly used for
these purposes. Otherwise, analytical chromatography is used to obtain quantitative and
qualitative information about the compound of interest (analytes) in a sample. Analytical
chromatography is done normally with smaller amounts of material and is used for
measuring the relative portions of analytes in a mixture. Analytical separations of solutions
for detection or quantification normally use more sophisticated HPLC instruments (Levin,
2001; Lindholm, 2004).
As an analytical technique, HPLC is usually projected for the separation and
determination of organic and inorganic solutes in any samples. However, HPLC can also be
preparative because it is basically a highly improved form of column chromatography. The
solvent is forced through under high pressures of up to 400 atmospheres on HPLC while
column chromatography uses gravity. That makes HPLC much faster and allows a very
small particle size for the column packing material, which provides a much greater surface
area for interactions between the stationary phase and the molecules flowing past it. So a
better separation of the mixture will be obtained. In addition, another major improvement
concern the detection methods which can be used. These HPLC methods are highly
automated and extremely sensitive (Clark, 2007). In principle, all LC and HPLC work in
the same way, however HPLC is more efficient, sensitive and easier to operate. HPLC is
now becoming one of the most dominant instruments in analytical chemistry, not just
because of ability to separate, identify and quantify the compounds, but parts per trillion
[ppt] sample may easily be identified by HPLC (Anon, 2011).
The instrumentation components in HPLC system are the pump, injector, detector
and data station, whereas the chemical components are the mobile phases and the stationary
phases (Levin, 2001). Sometimes, HPLC is connected to an auto sampler that makes it
easier to inject and allows the analyst to analyse samples in large numbers (usually up to
100 samples) for unattended automatic operation. A schematic of the HPLC system can be
seen in figure 1.12.
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Figure 1.12 Schematic of an HPLC System (Levin, 2001).
Running an HPLC can be conducted by injection of liquid sample in a small volume
into a column (stationary phase) where the individual components of the sample are moved
down with mobile solvent forced at high pressure using a pump. These components are
separated by the column packing contains various chemical and/or physical interactions
between their molecules and the packing particles. These separated components are
detected by a detector that measures their amount. This detector produces a chromatogram.
An auto sampler is an important alternative device for the ease of the analyst when a lot of
samples need to be analysed at the same time, such as in drug clinical trials analysis or
further analysis for preparative chromatography fractions.
In many respects HPLC and Gas Chromatography (GC) are complementary
techniques. HPLC is the recommended technique for wide range of sample types whose
analysis by GC can be quite difficult. High boiling or non volatile samples, proteins,
polymers, ionic compounds, and thermally unstable compounds are all candidates for
analysis by HPLC. Volatile samples, especially in complex mixtures, on the other hand, are
more appropriately analyzed by GC. HPLC typically offers more flexibility than does GC.
These results in part come from the participation of the mobile phase (the solvent system)
in the separation of chemistry of HPLC (Harris, 2005).
Based on interactions between the sample, stationary phase and mobile phase, most
of the separations by HPLC can be placed in one of five categories called modes. (1)
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Reverse-phase LC is based on distribution of the sample between a polar mobile phase
(usually water-containing) and a non polar stationary phase. (2) Normal-phase LC is
generally intended that the mobile phase is non polar compared to the stationary phase. In
practice, normal-phase LC is often used synonymously with “adsorption’ chromatography.
It is driven by interaction between the sample and the solvent with polar active sites on the
surface of the packing material. (3) Ion-exchange LC, as the name implies, depends on
exchange of sample or buffer ions between the mobile phase buffer and charged groups on
the stationary phase. (4) Ion-pair chromatography uses a reversed-phase column and a
“soapy” ion-pair reagent to create an ion exchange system. (5) Size-exclusion
chromatography separates on the basis of the extent to which the sample molecule can
penetrate the pores of the packing material. As the name implies, the separation is based on
molecular size (Dolan, 2007). There are seven basic considerations in choosing HPLC
operating parameters to work with i.e. solubility, molecular weight, functional groups,
sample matrix, levels in matrix, detection ability, and how the species differ (Levin, 2001).
Detection in HPLC can take advantage of a wide range of sample and solvent
characteristics. Compared to GC that has Flame Ionization Detector (FID), LC lacks the
sensitive/universal detector. Commonly used HPLC detection techniques include ultra
violet (UV) or visible light absorbance, refractive index or conductivity monitoring,
fluorescence measurement, amperometric or coulometric redox, chemical dramatisation,
and even more elaborate techniques such as chemiluminescence or mass spectroscopy. The
most common is the UV detector, known as photodiode array (PDA) when it can measure a
wide range of UV wavelengths at once. UV detection requires the compounds to absorb
UV light. Conjugation of the molecule does this i.e. an alternating double bond, single
bond, double bond. Therefore aromatic compounds show the absorption but fats and sugars
typically do not. For them, another detection method must be employed, such as
evaporative light scattering detection (ELSD). This is another common detector which is
destructive, so it is not used on preparative systems, but is universal as long as all
components have a boiling point higher than that of the solvent used for the mobile phase.
PDA detection, the most common HPLC detector, generates 3D data which can be viewed
in 3 ways as 2 dimensional data with 2 axes.
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1.2.5.2 Column Characteristic
The column is considered the “heart of the chromatograph”. In conducting an
analysis using the HPLC, selection of the column or stationary phase is very important for
the purpose of analyte separation because an inappropriate column might cause inefficient
separation. Characteristics of a good column are influenced by several factors such as pore
size, particle shape and size distribution as well as the length and diameter of the column
itself. Substrate materials inside the column are also critical in affecting of separation.
Usually the column contains silica or polymeric substrates of different pore size. Pore size
can be defined by the ability of the analyte molecules to penetrate inside the particle and
interact with its inner surface (Levin, 2001). In this case, the column packing and the
mobile phase are the most important factors in successful HPLC analysis.
Several types of column can be selected in the application of HPLC depending on
the purpose. A column for analytical purposes usually has an internal diameter (i.d.) 1.04.6-mm; lengths 15–250 mm while for preparative purposes the i.d. > 4.6 mm ; lengths 50–
250 mm. Capillary columns are also used for analytical HPLC and usually have i.d. 0.1-1.0
mm in various lengths. This column offers performance plus flexibility, versatility and ease
of use. Nano column is a capillary column which has i.d. < 0.1 mm or sometimes stated as
< 100 µm.
Materials of construction for the tubing usually are metal which is chemically inert
to virtually all common solvents and buffers and easy to cut, however has disadvantages
including limited pressure capability, permeability to air and oxygen and tendency to cold
flow; stainless steels (the most popular gives high pressure capabilities); glass (mostly for
bio-molecules) and polyether ether ketone (PEEK) that can be operated at elevated
pressure, biocompatible and chemically inert to most solvents except tetra hydro furan
(Dolan, 2007).
Another thing that is also important is the effect of the separation mode. The
chemical and physical properties of the analyte should be considered too. Analytes with
low to intermediate polarity and high solubility in low-polarity solvents will get a better
separation in normal phase chromatography while water-soluble analytes are usually not
good candidates for normal-phase chromatography. Reverse phase chromatography using a
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RP-column is useful for the separation of compounds having high to intermediate polarity
and ion-exchange chromatography separates analytes by their ionic functionality

1.2.5.3 Isocratic and Gradient
Solvent composition of the mobile phase in a chromatography creates the chemical
environment for the interaction between the solutes and the stationary phase. Separation
can be achieved by controlling and manipulating these interactions, which affect the
relative retention times of the various sample components.
Mobile phase parameters which influence retention and separation in reverse-phase
includes type of modifier, solvent strength, pH, type of buffer, ionic strength and ionpairing reagents. Most separations on HPLC are done with reverse-phase, probably over
90%. In reverse-phase separations of organic molecules, separations are based on their
degree of hydrophobicity. There is a correlation between the degree of lipophylicity and
retention in the column. In normal-phase HPLC, the polar solutes elute later than non-polar
lipophylic ones (Dolan, 2007).
There are two modes of operation for mobile phase composition:
1. Isocratic Elution which has constant solvent composition where mobile phase
polarity stays constant throughout elution process. Isocratic elution creates
increasing dispersion as a function of efficiency (N), void volume (VO) and
retention (k), causing lower sensitivity for more retained solutes. Isocratic elution is
best for simple separations and often used in quality control applications that
support a manufacturing process. This is equivalent to isothermal separations in GC.
2. Gradient Elution where mobile phase composition (and thus polarity) varies
throughout elution process. Gradient elution focuses sample components at the
column inlet and creates uniform dispersion of all solutes by reducing and
eliminating the retention factor aspect. This is best for the analysis of complex
samples and often used in method development for unknown mixtures. This is
equivalent to temperature programming in GC. Linear gradients are most popular.
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1.2.5.4 Acidic Additives to Mobile Phase
The acidity or alkalinity of the mobile phase can have a significant effect on
separation. Acetic acid and triethylamine are two traditional mobile phase additives that are
commonly used in reverse phase HPLC (Li, 2010). An acid mobile phase additive impacts
the retention behaviour of pH-sensitive compounds.
The use of mobile phase additives might enhance the separation and resolution of
the bioactive compounds in the HPLC analysis of a medicinal plant. However this must be
considered with the nature of particle substrates contained in the column itself. The C18
column for example, which has a hydrocarbon bonded phase, will be damaged if the pH is
higher than 8.0. That is why using sodium hydroxide solution as a mobile phase additive in
C18 and C8 columns must be done with care. On the other hand, the silica contained in the
C18 column will dissolve when the pH is less than 2.0. Therefore, for longer life the column
which has chemically bonded carbon and silica inside, the pH should be ranged between
2.0 to 8.0. It is also important to wash column from acid because leaving the column
overnight with acid from the mobile solvent will make the silica porous and destroy the
column in a short time (Dolan, 2007).
1.3 OBJECTIVES
1.3.1 General Objective
The increasing number of various herbal medicines and complementary products on
the market requires reliable quality control and standardisation of the products to protect
the consumers. This requires acceptable reference standards for qualitative and quantitative
analysis of the products. This study aimed to develop an efficient method for isolation and
purification of natural compounds from medicinal plants as reference materials for quality
control and standardisation of the products using liquid flow processing The production of
purified α-mangostin from Garcinia mangostana L. rinds in one step is used as an example.

1.3.2
•

Specific Objectives

To provide a reference standard with high purity and yield for quality control and
standardisation of natural based products
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•

To isolate and purify natural compounds from a medicinal plant using liquid flow
processing

•

To develop a method for isolation and purification of α-mangostin using liquid flow
processing

•

To optimise a method in analytical scale for the production of α-mangostin with high
purity and yield with a simpler process, with reduced processing time and less solvent
use, by Mini high performance counter-current chromatography (HPCCC)

•

To scale up the production of purified α-mangostin using the optimised method from
analytical scale to Spectrum HPCCC and Midi HPCCC

•

To ensure the identity and purity of Components through identification and
characterisation by High Performance Liquid Chromatography (HPLC) with
comparation to a commercial reference standard, and Nuclear Magnetic Resonance
(NMR) Spectroscopy
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Chapter 2 MATERIALS AND METHODS
2.1 MATERIALS
2.1.1 Crude Sample

Figure 2.1 Mangosteen fruit, rinds powder and ethanol extract
The dry powder of mangosteen (Garcinia mangostana L.) fruit rinds, as a sample of
this research, was purchased from Bina Agro Mandiri Yogyakarta Indonesia. The
mangosteen sample was collected from Kulon Progo area in February 2011. The drying
was performed in an oven at 60 °C for 3 hours to ensure the materials were completely dry,
then were ground into powder and passed through a sieve with 90 mesh size. The dry
mangosteen rind powder was stored in an airtight plastic container protected from light
until used. The mangosteen was authenticated by Sujadmiko, Faculty of Biology Gadjah
Mada University Yogyakarta Indonesia with certificate number 0300/T.Tb./I/2012.
2.1.2 Reference Standard

Figure 2.2 Reference standard of α-mangostin
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Reference standard of α-mangostin with purity ≥98% was a product of China; with
lot number #051M1495V; P code 10011345133; CAS number 6147-11-1; and was
purchased from Sigma Aldrich (Gillingham, UK).
2.1.3 Chemicals and Consumables

Figure 2.3 Chemicals
Organic solvents such as ethanol, hexane, ethyl acetate, and methanol were
analytical reagent grade. Methanol and trifluoroacetic acid (TFA) for mobile phase on
HPLC were HPLC grade. Molecular sieve for drying methanol was general purpose grade
type 4 A with nominal pore size 4 A. The chemicals were purchased from Fisher Chemicals
(Loughborough, UK).

Figure 2.4 Consumables
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Consumables i.e. HPLC vials, pipette tips, glass tubes and plastics tubes for fraction
collection, were supplied from Fisher Scientific (Loughborough, UK). Other consumables
were disposable syringes and needles (BD PlastipakTM), filter paper (Whatman no 113),
centrifuge tubes (Eppendorf) and deionised water and HPLC water was purified from a
Purite Select Fusion pure water system (Thames, UK).
2.2 APPARATUS
2.2.1 HPCCC Instruments
HPCCC was made by Dynamic Extractions (Slough, UK), and employed for the
separation and isolation of Components including sample loading studies and development
of an efficient method for production of α-mangostin. There were 3 scales used in this
project, with specifications presented on table 2.1. as follows:
Table 2.1 Specifications of HPCCC centrifuges
PARAMETERS
Image

MINI
HPCCC

Instrument Scale Analytical

SPECTRUM
HPCCC

MIDI
HPCCC

Semi Preparative

Preparative

Coil volume
(mL)

20

22 and 132

1000

Flow rate
(mL/min)

0.5 - 2

0.5 - 12

10 - 80

Loading (g/run)

Up to 0.2

Up to 2

5 to 40

Rotational Speed 2100
(@240g (RPM)

1600

1400

20
Approximate
elution time for
KD=1 component
(min)

20

20
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2.2.2 High Performance Liquid Chromatography (HPLC)

Figure 2.5 Waters Alliance 2695 Separations Module HPLC
The HPLC was Waters Alliance 2695 Separations Module (Milford, MA, USA),
equipped with isocratic and gradient pumps at a maximum flow rate of 10 mL/min. The
instrument was also fitted with an auto sampler with 120 vials configured in five carousels
of 24 vials each. Detection system was Waters Photodiode Array Detector 2996 and
Empower2TM Chromatography Data software was employed as a data processor.
The Empower software is capable of automating method development, archiving methods
and customizing data reports. This HPLC was used to analyse α-mangostin from crude
extract and CCC fractions using a commercial reference standard.
2.2.3 Nuclear Magnetic Resonance Spectrometer

Figure 2.6 Brüker Avance III HD 600 MHz FT-NMR Spectrometer
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The NMR was Brüker Avance III 600 MHz FT-NMR Spectrometer with Spin
Works 3 Data Processor (Germany) housed and operated in the Department of Pharmacy
and Chemistry, Kingston University. The Spin is a software package for acquiring,
processing and analyzing NMR data, for streamlined convenience. This instrument was
applied for the characterisation of α-mangostin isolated from the fruit rinds of Garcinia
mangostana L.
2.2.4 Supporting Equipment

Figure 2.7 Supporting equipment e.g. (clockwise from top left) rotary concentrator,
touch mixer, water bath and fraction collector
There were several items of supporting equipment that were used in this study, such
as analytical balance (Sartorius), rotary evaporator (Büchi Rotavapor R205 with Büchi
Heating Bath B-490), rotary concentrator (Eppendorf Concentrator 5301), fume cupboard
(Zurich L 12-3), centrifuge (Sanyo MSE Micro Centaur), touch mixer (Top Mix FB
15024; Fisher Scientific), vacuum pump (Laboport), water bath (Grant), micropipette
(Eppendorf), ultra sonic bath (Sonomatic Jencons), fraction collector for Mini and
Spectrum HPCCC (Teledyne ISCO Foxy Jr.), fraction collector for Midi CCC (Gilson
Model 202), Rotary wheel (Stuart Rotator SB3), HPLC Column: Agilent Zorbax Bonus RP
C18 with dimension (3.5um; 4.6x150mm), buchner funnel, separating funnel and glassware
(Fisher brand).
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2.3 METHODOLOGIES
2.3.1 Optimisation of Analytical Method for α-Mangostin by HPLC
2.3.1.1 Preparation of HPLC Mobile Phase
Into 1000 ml methanol HPLC grade and 1000 ml fresh deionised water in separate
containers was added 500 µL TFA each. The mixtures were well shaken and filtered using
a Millipore filter with pore diameter of 0.45 µm under vacuum condition if needed. The
mixtures were prepared freshly before use.

Figure 2.8 Methanol and water, to which 0.05% TFA was added for the HPLC
mobile phase
2.3.1.2 Optimisation of analytical condition for α-Mangostin using HPLC
Optimisation of analytical condition was conducted on Waters Alliance 2695
Separations Module HPLC which was equipped with photo diode array (PDA) UV
detector. An Agilent Zorbax Bonus RP-C18 (3.5µm; 4.6x150mm) column was selected
among several columns as a stationary phase; run time 12 min; temperature 40°C; detection
range at 210-400nm with a binary mobile phase consisting of 0.05% TFA in water (solvent
D) and in methanol (solvent C) at a flow rate of 0.5 ml/min. The gradient elution program
was as follows: 0-3.00 min, 95-100% C; 3.00-8.00 min, 100% C; next injection at 14 min
after column equilibration. Data was collected over 12 min run time.
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The optimised method was then used to assay the standard solution made from
commercial α-mangostin reference standard and to create a calibration curve; then to
analyse the crude extract as well as CCC fractions. The low limit of detection (LLOD) was
determined based on the results of sample measurements that provided a peak height with 3
times base line noise i.e. signal to noise ratio S/N=3.
2.3.1.3 Preparation of Standard Solution I
Standard solution I for the calibration curve of α-mangostin was prepared in the
following manner: Approximately 1.2 mg α-mangostin reference standard was weighed
accurately, 5.0 mL dry methanol added by pipette. The mixture was weighed again in order
to calculate the true volume of methanol added and mixed evenly, labelled as standard
solution I; and 1 mL was transferred into an HPLC vial, analysed for the calibration curve I.
The true volume of methanol in the α-mangostin standard solution was calculated
by the following formula:

V =

M

ρ

V = volume; M = Mass; and ρ = density.
Methanol density is 0.7918 g cm−3 (value from Wikipedia), approximately 20⁰C which is
likely to be the room temperature at the time
Dry methanol was prepared in a flask by adding some molecular sieves into
methanol HPLC grade, shaken vigorously and left overnight.
2.3.1.4 Preparation for Standard Solution II
Standard solution II was a 25 times dilution of standard solution I. Preparation was
carried out as follows: Into a volumetric flask, 2.0 mL α-mangostin standard solution I was
pipetted accurately and dry methanol added up to 50.0 mL at temperature of 20⁰C. The
solution was mixed evenly, labelled as standard solution II. 1 mL was transferred into an
HPLC vial, analysed for the calibration curve II.
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2.3.1.5 Preparation for Calibration Curve
To prepare calibration curves, the standard solution II was injected with successive
volumes: 2, 5, 10, 15, 20, 25, 30, 40 µL and the standard solution I was injected with
successive volumes: 2, 5, 10, 15, 20, 25 µL respectively into HPLC with optimised
conditions as decribed on 2.3.1.2. The calibration curves were created by plotting the
amount vs. peak area of each standard solution injected. The data from standard solution I
was plotted for calibration curve I and the data from standard solution II was plotted for
calibration curve II.
2.3.1.6 Preparation for Aqueous Ethanol Extract as Stock Solution

Figure 2.9 Preparation of aqueous ethanol extract with overnight maceration (left)
and extract filtration under vaccum (right)
100 gram crude powder was macerated overnight in 700 ml of 80% ethanol at 30⁰C
with occasionally stirring. The mixture was then filtered under vacuum using Whatman
filter paper number 113. The pulp was added to 500 mL 80% ethanol, stirred, left for about
1 hour and filtered in the same manner. The filtrates were combined and the extract yield
measured before drying down using rotary evaporator at 35 rpm, 45⁰C. To remove water
from the syrup extract, about 200 mL methanol was added into the extract and drying
continued. When completely dry, the extract was then re-dissolved in methanol or lower
phase (LP) accordingly and used as a stock solution for further experiments.
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2.3.1.7 Measurement of the Extract Yield
An empty vial was weighed accurately, 5.0 mL macerate added and weighed again.
The macerate was dried down using a rotary concentrator and the dry extract was weighed
again until stable. The yield was calculated as a percentage of dry extract in mangosteen
rinds powder. The measurement was conducted in triplicate.

Figure 2.10 Dry extract from macerates
2.3.1.8 Crude Extract analysis on HPLC
Analysis of the crude extract was performed on HPLC in the following manner: 1020 µL of stock solution in LP was transferred into an HPLC vial and dried down using a
rotary concentrator. 1000 µL methanol was added and mixed well. 5 µL solution was then
injected into HPLC and analysed under the same analytical conditions as used for the
preparation of the calibration curve. The peak area of α-mangostin was calculated using the
calibration curve especially to determine the recovery of α-mangostin injected on HPCCC.
Sample from stock solution in methanol could be directly injected into HPLC without
drying down the solvent.
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2.3.2 Optimisation of an Efficient Method for Production of α-Mangostin using
HPCCC
2.3.2.1 Solvent System Selection and Partition Coefficient (KD) Measurement
Into a vial containing an accurate weight of approximately 5 mg of mangosteen
crude material was added 5.0 mL of several HEMWat solvent systems from the literature
study i.e. HEMWat (1:1:1:1 v/v), (5:5:10:4 v/v), (8:8:10:6 v/v) and (10:10:5:1 v/v).

Figure 2.11 Partition coefficient measurement
The mixtures were shaken and then left to settle for about 30 min until the phases
were completely separated. Into HPLC separate vials, 0.5 mL upper phase and 0.5 mL
lower phase of each mixture was delivered respectively and the solvent dried down in a
rotary concentrator. 1.0 mL methanol was added into the vial and mixed evenly. Before
analysing in HPLC, if required the mixture was centrifuged at 13,000 rpm for 5 min to
avoid column blockage by crude particles. The solvent system which had a suitable KD=1
was selected as solvent system for this study. The experiment was done in triplicate
2.3.2.2 Settling Time Measurement

Figure 2.12 Settling time measurement using graduated cylinder
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The procedure was as follows: the two phases of the chosen HEMWat solvent
system were first equilibrated in a separating funnel; 2.0 ml of each phase (lower and upper
phase), a total volume of 4.0 ml, was delivered into a graduated cylinder, which was then
capped. The container was gently inverted for several times and then immediately placed it
in an up-right position to measure the time required for the two phases to form clear layers
with a distinct interface (Ito, 2005).
2.3.2.3 Extraction Kinetics Studies Using Rotary Wheel

Figure 2.13 Extraction kinetic studies on a rotary wheel
Into several tubes containing an accurate weight of approximately 250 mg crude
mangosteen powder each were added 25 mL UP, LP and UP+LP (50:50) respectively. The
tubes were placed on a rotary wheel and were rotated for 30 min, 60 min, 90 min, 360 min,
overnight (16 hours), and 2 days. In every completion time, 100 µL extract was taken from
the tubes into an HPLC vial and dried down using rotary extractor. After completely
drying, 1.0 mL methanol was added into vial and mixed evenly. The solution then was
analyzed by HPLC using the same condition as in the calibration curve analysis with an
injection volume of 10 µL each. The experiment was performed in triplicate.
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2.3.2.4 CCC Procedure
2.3.2.4.1 Solvent System Preparation for CCC
Classical preparation of the HEMWat solvent system for CCC was conducted shortly
before use by thoroughly mixing hexane/ethyl acetate/methanol/water in ratio of 5:5:10:4
(v/v) respectively. The mixture was equilibrated in a separating funnel at room temperature
for about 30 min and the upper phase (UP) and lower phase (LP) separated. The upper
phase was used for stationary phase and the lower phase used as mobile phase.

Figure 2.14 Solvent system preparations using a separating funnel
2.3.2.4.2 Sample Preparation for CCC
To prepare sample for CCC, the extract was dissolved in mobile phase (LP). The
stock solution dissolved in methanol was dried down and re-dissolved in LP. The
preparation was done by drying 5.0 mL of the stock solution in a rotary concentrator to
remove the solvent. The dry extract was then re-dissolved in LP to the original volume of 5
mL and used for sample loading studies with dilution using the following equation,

C1 × V1 = C 2 × V2
Where C1 is initial concentration or molarity, V1 is initial volume, C2 is final concentration
or molarity, and V2 is final volume. Sample from stock solution in LP could be directly
diluted at the same manner without drying.
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Figure 2.15 Dry extract from stock solution in methanol and the extract after redissolving in LP

2.3.2.4.3 Operating CCC
2.3.2.4.3.1 Analytical Scale Mini HPCCC Centrifuge
The Mini-CCC centrifuge used for analytical separations and the sample loading
studies was previously described in detail by Janaway et al (2003). It has a rotor radius of
50mm, tubing bore of 0.8mm, mean β of 0.74 and a single bobbin of 5.4mL capacity with a
counter weight. The Mini can be rotated up to a speed of 2100 rpm (246×g) and has a
typical flow range for most organic/ aqueous phase systems of 0.5–2 mL/min for a
separation, but the Mini column can cope with flow rates up to 10 mL/min (w.r.t. pressure)
for refilling (Sutherland, 2009). The system was equipped with one Hewlett Packard series
1100 pump with 4 different lines that are suitable for 4 different solvents. Detection system
was a Knauer K-2501 UV detector (Berlin, Germany) which was set at 240 nm to monitor
the elution process. The fractions were collected using Teledyne ISCO Foxy Jr. fraction
collector (Lincoln, USA) and the data was processed using Euchrome 2000 Data Processor.
The operating procedure for Mini was done with equilibration of the column before
injection. A 50 mL graduated cylinder was placed at the end of the tubing (tail), then the
stationary phase was initially pumped into the column at a flow rate of 5 mL/min with no
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rotation until at least one complete coil volume of stationary phase came out into the
cylinder. The coil was then rotated at 2100 rpm at temperature 25 ⁰C. The mobile phase
was pumped from head to tail at a flow rate of 1 mL/min. In order to observe the volume of
stationary phase eluted from the column, the resulting effluent was collected in a 25 mL
graduated cylinder. The hydrodynamic equilibrium was considered to be established when
the stationary phase was no longer dripping into the cylinder (usually when the two phases
volumes of the eluent were approximately equal) and the machine was ready to be injected.
The sample solution was injected with the desired concentration up to 107 mg/mL or
volume up to 1.8 mL into the column, the fraction collector started, and the recorder turned
on. All fractions were collected at 1 min/tube within elution time. At the end of the run, the
column was emptied of stationary phase by pumping the mobile phase at a higher flow rate
without rotation. The stationary phase was collected and analysed on HPLC in the same
manner as on fractions, to ensure all the mangostin had eluted. For multiple injections, the
injection time was every 25 min. Concentration of α-mangostin was calculated by viewing
peak area from the calibration curve after analysis by HPLC.
2.3.2.4.3.2 Semi Preparative Scale Spectrum HPCCC Centrifuge
The Spectrum HPCCC instrument was initially described by Guzlek et al (2009).
The equipment that was employed in this project was manufactured by Dynamic
Extractions (Slough, UK). The machine comes with two sets of two multilayer columns on
two bobbins, i.e. four columns on two bobbins. These two sets were designated as
analytical and semi-preparative columns, respectively. Their tubing bore was 0.8 mm for
analytical coils and 1.6 mm for semi-preparative coils, respectively with 22 and 136mL
total column volumes. In this study the semi-preparative columns were employed. The βvalue of these coils varied from 0.52 to 0.86. The rotational speed can be varied up to 1600
rpm and the instrument, which has an integrated temperature controller, was set to 25 ⁰C
for all runs. The system was equipped with an Agilent Technologies 1200 series isocratic
pump (California, USA) and detector using photodiode array detection system (Milford,
MA, USA). The fractions were collected using Teledyne ISCO Foxy Jr. fraction collector
(Lincoln, USA).
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Column equilibrium must also be performed before operating Spectrum HPCCC. A
200 mL graduated cylinder was placed at the end of the tubing (tail), then the stationary
phase was initially pumped into the column at a flow rate of 40 mL/min with no rotation
until at least one complete coil volume of stationary phase came out into the cylinder. The
mobile phase was pumped from head to tail at a flow rate of 4-8 mL/min while the
centrifuge was rotated at 1600 rpm, 25 ⁰C. In order to observe the volume of stationary
phase eluted from the column, the resulting effluent was collected in a 100 mL graduated
cylinder. The hydrodynamic equilibrium was reached when the stationary phase was no
longer dripping into the cylinder and the machine was ready to be injected. The sample
solution was injected with the desired concentration or volume into the column, the fraction
collector started, and the recorder turned on. All fractions were collected at 1 min/tube
within elution time. At the end of the run, the column was emptied from stationary phase
by pushing out the stationary phase in each bobbin separately using compressed air at a low
rotation (215 rpm). The stationary phase was collected in separate cylinder and analysed on
HPLC in the same manner as on fractions. For multiple injections, the injection time was
every 25 min. Concentration of α-mangostin was calculated by viewing peak area from the
calibration curve after analysis by HPLC.
2.3.2.4.3.3 Preparative Scale Midi HPCCC Centrifuge
The Midi-CCC centrifuge was manufactured by Dynamic Extractions (Slough, UK)
and the setup used for the study was described in detail by Hewitson et al. (2009). It has a
rotor radius of 110mm, tubing bore of 4mm and two bobbins (columns) with a total
capacity of 912.5 mL. The Midi can be rotated up to a speed of 1400rpm (241×g), has a
typical flow range of 10–100 mL/min and a mean β value of 0.75 where β is the ratio of
planet to rotor radius (Sutherland, 2009). This instrument was fitted with a sample injector,
a Knauer pump K 1000 (Berlin, Germany) which has maximum flow rate 1000 mL/min
and a Knauer detection system K 2501 UV detector (Berlin, Germany) as on Mini. Data
processor was Euchrome 2000. The fraction collector was Gilson Model 202 (France). The
wave length detection was set at 240 nm as optimum wave length of mangostin.
The operating procedure for Midi was done with equilibration of the column before
injection. A 1000 mL graduated cylinder was placed at the end of the tubing (tail), then the
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stationary phase was initially pumped into the column at a flow rate of 200 mL/min with no
rotation until at least one complete coil volume of stationary phase came out into the
cylinder. The coil was then rotated at 1400 rpm, 25 ⁰C. The mobile phase was pumped
from head to tail at a flow rate of 20-50 mL/min. In order to observe the volume of
stationary phase eluted from the column, the resulting effluent was collected in a 500 mL
graduated cylinder. The hydrodynamic equilibrium was considered to be established when
the stationary phase was no longer dripping into the cylinder and the machine was ready to
be injected. The 50 mL sample solution was injected with the desired concentration into the
column, the fraction collector started, and the recorder turned on. All fractions were
collected at 1 min/tube within elution time. The fractions were analysed on HPLC after
drying down the solvent. At the end of the run, the column was emptied from stationary
phase by pushing out the stationary phase in each bobbin separately using compressed air at
low rotation (215 rpm). The stationary phase was collected and analysed on HPLC in the
same manner. For multiple injections, the injection time was every 25 min. Concentration
of α-mangostin was calculated by viewing peak area from the calibration curve after
analysis by HPLC.
2.3.2.4.3.4 Procedure of analysis for CCC Fractions on HPLC

Figure 2.16 Fraction preparation for analysis on HPLC, fraction drying in a
rotary concentrator
Analysis of the HPCCC fractions was carried out on HPLC in the following
manner: 100 µL of the fraction was transferred into an HPLC vial and dried down using a
rotary concentrator. 1000 µL methanol was added and mixed well. 5 µL solution was then
injected on HPLC under the same analytical conditions for the preparation of the
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calibration curve. All peak areas that appeared on the HPLC chromatogram were plotted on
a fractogram (a reconstructed chromatogram). These data were used to calculate the purity
and yield of α-mangostin. From the fractogram, the resolution (RS) between α-mangstin
and the nearest component peaks (component 3) was calculated using equation on page 13.
The stationary phase extracted from the column was analysed on HPLC in the same
manner.
2.3.2.5 Nuclear Magnetic Resonance (NMR) Spectroscopy Procedure
This NMR experiments were conducted in Kingston University London. The
procedure which was done and reported by E Keaveney from School of Pharmacy and
Chemistry was as follows:
1.

Preparation of initial NMR standard solution, 1 ml of deuterated chloroform was added
to the vial that contained the alpha-mangostin standard supplied by Sigma-Aldrich. The
resulting solution was then filtered into an NMR tube through cotton wool in a
disposable pipette. A drop of TMS (tetra methyl silane) was added to the NMR tube
which was then shaken to disperse the TMS.

2.

Preparation of second NMR standard solution: the initial NMR standard preparation
(1) was transferred from the NMR tube to a sample vial. The solution was taken to
dryness using a stream of nitrogen. 0.75 ml of acetonitrile was added to the sample vial
using disposable pipettes. The sample was transferred back to the NMR tube by
filtration through a cotton wool filter using disposable pipettes. A drop of TMS was
added to the NMR tube and it was covered and shaken to fully disperse.

3.

Preparation of sample: in a vial containing 8 mg sample (indicated pure α-mangostin)
from a combined HPCCC fractions (EKSM23F2021) prepared by Brunel University
London, was added 0.75 ml of acetonitrile using disposable pipette. The sample was
transferred to a glass NMR tube by filtration through a cotton wool filter using
disposable pipettes and labelled with the sample codes. A drop of TMS was added to
the NMR tube, which was then shaken to fully disperse and analysed.
To analyse on NMR, the sample tube was then placed inside a cylindrically wound

magnet and exposed to a pulsed magnetic field which cause the nuclei within the sample to
become first excited then relaxed. The resonance produces a signal characteristic to the type
49

of isotope in the sample which is then recorded. This signal is integrated to produce a series
of spectral lines.
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Chapter 3 RESULTS AND DISCUSSION
3.1 Optimisation of Analytical Method for α-Mangostin by HPLC
Table 3.1 Optimised conditions of HPLC
No HPLC
Parameters
1. Column
2.
3.
4.

Temperature
Flow rate
Mobile phase

5.

Elution program

6.
7.
8.
9.

Run time
Delay time
Collecting data
Wave length
detection
Low limit of
detection (LLOD)
Retention time of
α-mangostin

10
11

Optimised Conditions of HPLC
Agilent Zorbax Bonus RP C18 with dimension
(3.5um; 4.6x150mm)
40 ⁰C
0.5 mL/min
Methanol with 0.05% TFA (C)
Water with 0.05% TFA (D)
Gradient system:
0-3 min: 95-100% C;
3-8 min: 100% C;
12 min
2 min
12 min
PDA Max Plot 210 nm to 400 nm
0.000008 µg/µL (8 ppm)
6.00 – 6.50 min

As described previously, the optimisation of an analytical method for α-mangostin
on HPLC began with a literature study. Based on previous research (Jia, 2007; Jujun, 2009;
Syamsudin, 2010), a C18 column and methanol/water were selected as stationary phase and
mobile phase respectively for analysing α-mangostin on HPLC.
In this research, the column selected was Agilent Zorbax Bonus RP-C18 with
dimension 3.5µm; 4.6x150mm. The column had small particles size that provided a greater
surface area for interactions between the stationary phase and the molecules flowing past it.
So a better separation of the mixture was obtained (Clark, J., 2007). In addition, with an
appropriate dimension of the column, it also produces a good pressure approximately 700
psi.
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Analytical conditions were maintained at a temperature of 40 ⁰C where it was a high
enough temperature to reduce solvent viscosity and the chance of column over-pressure but
non destructive to α-mangostin and other Components in the extract. The flow rate and
elution program were set in order to create a chromatogram with good separation. The run
time of 12 min was optimised to a minimum time that was able to elute all compounds in
the extract. The delay time was needed to remove all compounds that might remain at the
end of elution which interfere with the peaks from the next injection. When preparing the
solvent system for HPLC, 0.05% trifluoroacetic acid (TFA) was added to methanol HPLC
grade and to fresh ionised water separately as an ion pair reagent to remove tailing of the
peaks.
3.2 Preparation of Standard Solution
Table 3.2 Calculation of α-mangostin standard solution for calibration curve
Parameters

Results

α-Mangostin

1.2 mg

Vial and 1.2 mg α-Mangostin

8.2759 g

Vial and 1.2 mg α-Mangostin + 5.0
mL dry Methanol
Dry methanol

12.2217 g
3.9458 g

True volume of dry methanol

4.9833 mL

Concentration of α-Mangostin
standard solution I

1200
µg/mL = 0.2408 µg/µL
4.9833
9.632 µg/mL = 0.0096 µg/µL

Concentration of α-Mangostin
standard solution II (25xdilution)

Standard solution I was prepared by adding 5.0 mL dry methanol into a vial
containing an accurate weight of approximately 1.2 mg α-mangostin commercial reference
standard. After adding the dry methanol, the vial was weighed again to ensure the true
volume of dry methanol due to minimise errors that might occur in weighing of the
reference standard. The dry methanol was prepared in a flask by adding some molecular
sieve into methanol HPLC grade, shaken vigorously and left overnight. This molecular
sieve was intended to absorb water that probably present in methanol since methanol is
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hygroscopic. The true volume of methanol was calculated by V=M/ρ; where V is true
volume of methanol; M is Mass; and ρ is density of methanol (0.7918 g cm−3). Standard
solution II was 25 times dilution of standard solution I and prepared using the formula of
C1 x V1 = C2 x V2 (2.3.2.4.2).
3.3 Calibration Curves
3.3.1 Calibration curve I
Table 3.3 Amount of standard solution I injected on HPLC vs. HPLC peak area
Volume Amount
(µL)
(µg)

Peak Area
(µVolt*sec)

2

0.4816

4921765

5

1.2040

15194643

10

2.4080

31753001

20

4.8160

64215307

25

6.0200

80014555

Figure 3.1 Calibration curve I, peak area vs. amount of α-mangostin
The calibration curve of α-mangostin was intentionally made from 2 different concentration
of standard solutions to cope with a variety of concentrations of sample/fraction analysed,
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which have peak areas up to 80,000,000 µVolt*sec. The sample with peak area ≥ 5,200,000
µVolt*sec was calculated using calibration curve I while peak area < 5,200,000 µVolt*sec
was calculated using calibration curve II. Both calibration curves either from standard
solution I or standard solution II had the regression equations with the same R2=0.999
which mean both curves are linear and using the HPLC optimised method all x values were
uniformly distributed either side of x ; similarly, all the y values was uniformly distributed
about y . These calibration curves were used to calculate the amount/concentration of αmangostin in all samples including crude extract and HPCCC fractions during this study.
3.3.2 Calibration curve II
Table 3.4 Amount of standard solution II injected on HPLC vs. HPLC peak area
Volume Amount
(µL)
(µg)

Peak Area
(µVolt*sec)

2

0.0192

234364

5

0.0480

643434

10

0.0960

1295177

15

0.1440

1965049

20

0.1920

2629968

25

0.2400

3313694

30

0.2880

4017900

40

0.3840

5392568
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Figure 3.2 Calibration curve II, peak area vs. amount of α-mangostin
3.4 Preparation for 80% Aqueous Ethanol Extract as Stock Solution
Table 3.5 Sample preparation
No
1

Crude Material
(g)
100

Dry Extract
(g)
10.6721

Stock Solution
(mL)
62 (in methanol)

Yield
(%)
10.61

2

100

15.5898

55 (in methanol)

15.59

3

200

20.4970

100 (in LP)

10.25

200

20.3816

100 (in LP)

10.19

In an initial study of this project, extraction of α-mangostin using 80% ethanol
obtained a higher concentration of α-mangostin compare to methanol and ethyl acetate. So
the solvent was chosen for extraction of α-mangostin from the fruit rinds powder.
Preparation of the ethanol extract was done with overnight maceration in 80%
aqueous ethanol, the extract was then filtered under vacuum conditions and collected before
measuring the yield and drying in a rotary evaporator. Stock solution was prepared by redissolving the dry extract in methanol or in LP. When using stock solution in methanol as a
sample for separation on HPCCC, the methanol was removed by drying on rotary
concentrator and then re-dissolved in LP. Otherwise, the stock solution in LP was directly
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used as a sample on HPCCC without removing the solvent. It was noted; however that the
stock solution in LP was not as stable as in methanol so it was prepared fresher. Moreover,
the LP which contains ethyl acetate and hexane will absorbs UV; therefore it needed be
eliminated from the extract or fraction before analysing on HPLC.

3.5 Measurement of the Ethanol Extract Yield of Mangostin from Crude Material
Table 3.6 Crude extracts yield measurement
No

1

2

3

4

Weight
of
empty
vial (g)

Weight
of vial
with
extract
(g)

Weight
of
extract
(g)

7.3126

7.3710

0.0584

7.3158

7.3630

0.0472

7.1790

7.2415

0.0625

7.2713

7.3271

0.0558

7.1546

7.2262

0.0716

7.2948

7.3683

0.0735

7.3136

7.3670

0.0534

7.3211

7.3627

0.0416

7.1777

7.2425

0.0648

7.2096

7.2624

0.0528

7.1232

7.1763

0.0531

7.3378

7.3908

0.0530

Average
weight of
extract
in 5ml
(g)

Total
volume
of
solution
(mL)

Total
weight
of dry
extract
(g)

Weight
of crude
material
used
(g)

Yield
of
mangostin
(%)

0.0560

947

10.6060

100

10.61

0.0670

1164

15.5976

100

15.59

0.0533

1970

20.9870

200

10.25

0.0530

1924

20.3816

200

10.19

Measurement of the yield of ethanol extract was conducted before drying the whole
filtrates collected using a rotary evaporator. When weighing the dry extract for calculating
the yield, it was done several times until the weight of the extract was stable to ensure the
extract was completely dry; so the yield could be calculated accurately. The measurement
of the yield was actually intended particularly to predict the amount of the extract that
would be injected to HPCCC for the sample loading study. The range of mass/extract that
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is possible to be injected depends on the scale of the machine. Table 3.6 shows that 4
different preparation of ethanol extracts gave the yields 10.19% to 15.59%.

3.6 Crude Extract and Fraction analysis on HPLC

Figure 3.3 Chromatogram of mangosteen crude extract, analysed by HPLC with
analytical conditions as in table 3.1, injection amount 5µL and concentration loaded
approximately 0.5µg/µL

Figure 3.4 Chromatogram of purified α-mangostin in a sample fraction, analysed by
HPLC with analytical conditions as on table 3.1, injection amount 5µL and concentration
loaded approximately 0.1µg/µL.
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The Chromatograms above show the peak of α-mangostin from analysis on HPLC.
The α-mangostin peak was the major peak in the chromatogram of the crude extract (Figure
3.3.) indicating that α-mangostin is a major compound in the fruit rind of Garcinia
mangostana L. The sample from a fraction presents a chromatogram with single peak

(Figure 3.4). So it can be assumed that α-mangostin was isolated nearly pure using HPCCC
according to HPLC peak area at this UV wavelength.
3.7 Solvent System Selection and Partition Coefficient (KD) Measurement
Table 3.7 Partition coefficient (KD) as the results of 2.3.2.1.
No

Solvent
System
(v/v)

Concentration of
α-mangostin in UP
(Mean ± SD)

Concentration of
α-mangostin in LP
(Mean ± SD)

Partition
Coefficient (KD)

1

HEMWat
(1:1:1:1)

0.0494 ± 0.0002

0.0024 ± 0.0001

19.65 - 21.37

2

HEMWat
(5:5:10: 4)

0.0328 ± 0.0004

0.0333 ± 0.0009

0.97 – 1.00

3

HEMWat
(8:8:10:6)

0.0570 ± 0.0001

0.0174 ± 0.0003

3.23 – 3.32

4

HEMWat
(10:5:5:1)

0.0186 ± 0.0003

0.0458 ± 0.0008

0.40 – 0.40

Note that HEMWat refers to the solvent system consisting of hexane-ethyl acetatemethanol-water. Selection of the solvent system for the separation of compounds by
HPCCC requires consideration of the partition coefficient (also called the distribution ratio)
and the settling time of the phase system. It can be seen in the Table 3.7 that the hexaneethyl acetate-methanol-water (HEMWat) (5:5:10:4 v/v) provided a partition coefficient
(KD) of 0.97 – 1.00. This meets the requirement of the suitable KD value which is 0.5 ≤ KD
≤ 2.0 for separation using HPCCC. This phase system was selected as solvent system for
isolation and purification of α-mangostin from the fruit rinds of Garcinia mangostana L.
using HPCCC. If KD=1, the analyte will elute at the retention volume equal to the column
capacity regardless of the retention volume of the stationary phase (Ito, 2005). Having
KD=1 is a good point since the concentration of Component dissolved in UP is equal to the
LP. The separation can also be conducted either in normal phase or reverse phase by simply
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changing LP to stationary phase or mobile phase. In the present study, the separation was
selected with reverse phase mode since this solvent system was prepared classically using a
separating funnel it produced the LP volume almost 3 times more than the UP volume. So it
was better to choose reverse phase mode to balance solvent usage where more mobile phase
was needed than stationary phase.
3.8 Settling Time Measurement
Table 3.8 Settling time of HEMWat (5:5:10:4 v/v) solvent system (2.3.2.2)
No

Settling Time (sec)

1
2
3
Mean ± SD

9.45
8.37
9.12
8.98 ±0.55

The table above shows the average of settling time of solvent system selected i.e.
HEMWat (5:5:10:4 v/v) was 8.98 sec. To provided satisfactory retention of the stationary
phase over 50% of the total column capacity in a proper range of flow rates, the time
required for the two phases to form clear layers with a distinct interface is less than 20 sec
(Ito, 2005), so the solvent system selected met the requirement.
3.9 Study on Extraction Kinetics Using Rotary Wheel
Table 3.9 Percentage of α-mangostin extracted from the fruit rind of Garcinia
mangostana L. in HEMWat (5:5:10:4 v/v)
No

Time

UP
(%)

LP
(%)

UP+LP
(%)

1

30 min

2.77

2.79

2.82

2

60 min

2.7

2.91

2.94

3

90 min

2.79

2.91

2.96

4

180 min

2.98

3.02

3.08

5

360 min

2.94

3.17

3.05

6

Overnight

2.93

2.93

3.10

7

2 Days

3.22

3.09

3.22
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Figure 3.5 below shows the extraction of approximately 0.025 g of rinds with 25 ml
of either upper phase, lower phase or total phase that the α-mangostin extracted was
approximately 2.8% of the rind in just 30 min after rotation on a rotary wheel. There was
no significantly different percentage of α-mangostin extracted in UP, LP as well as UP+LP
of the HEMWat (5:5:10:4 v/v) phase system. The percentage of α-mangostin then increased
a little bit and reached at nearly 3% after 60 min rotation. This condition has remained
relatively stable for 2 days rotation, with the variation observed being assumed to be simple
experimental error.

Figure 3.5. Extraction kinetic of α-mangostin from the fruit rinds of Garcinia
mangostana L. (Percent vs. Time) with either upper, lower or totals phase system
(HEMWat 5:5:10:4 v/v)
3.10 Sample Loading Study
Sample loading study was conducted on an analytical scale Mini HPCCC
instrument. This method was a modification of the method described by Jia et al (2011) for
the isolation of major xanthones in Swertia mussotii using Centrifugal Partition
Chromatodraphy. The solvent system was selected based on the solvent that is commonly
used for the isolation and separation of natural materials by liquid flow processing, which is
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generally composed of hexane or heptane /ethyl acetate/methanol/water and is called
HEMWat. Applying the solvent system of hexane/ethyl acetate/methanol/water (5:5:10:4
v/v) for isolation of α-mangostin from fruit rinds of Garcinia mangostana L. provided a
suitable distribution ratio (KD=1) as mentioned above. The running conditions which
several parameters can be seen on Table 3.10 as follows:
Table 3.10 Optimised conditions of sample loading study
No

Parameters

Optimised Conditions

1

Instrument

Mini HPCCC

2

Column volume

17.4 mL

3

Bore

0.8 mm

4

Solvent system

HEMWat (5:5:10:4 v/v)*

5

Stationary phase

Upper phase

6

Mobile phase

Lower phase

7

Running mode

Reverse phase

8

Rotational speed

2100 rpm

9

Flow rate

1 mL/min

10

Temperature

25 ⁰C

11

Run time per injection

25 min

12

Number of injections

Up to 10 x

*H stands for hexane
Samples injected were a variety of extract amounts from 4.6 mg to 91.2 mg and
volumes from 0.86 mL to 1.8 mL. The experiments were done with single and multiple
injections up to 10 times with 25 min interval time between injections without any
replacement or topping up of the stationary phase. The interval time was considered based
on the elution time of α- mangostin that generally eluted after 17 min to 23 min using the
method conditions above.
Table 3.11 below shows the results of sample loading study. Ethanol extract that
was injected on Mini HPCCC up to 22.8 mg, showed a good separation and provided high
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purities and yields with high recoveries. The purity reached at least 98% and yield over 97
% with recovery not less than 99% in average. The resolutions were also good for most
injections from 4.6 mg – 22.8 mg crude extract. It can be seen on fractograms (an elution
chromatogram recontructed from the off-line analysis data) at Figure 3.6 to Figure 3.10.
below, the peaks of α- mangostin were separated well in most injections; however the
resolution decreased a little with the increasing number of injections, as well as
concentration of sample injected. This phenomenon probably occurs because more
viscous/concentrated samples injected into the solvent system will create a resistance/shock
of the solvent system that will cause a loss of stationary phase and dilation of the peak
(Berthod, 2009). The multiple injections with a long running time affected the loss of
stationary phase on Mini HPCCC. On the fractograms can be seen clearly that the distance
between α- mangostin peaks and other components were getting closer and closer with the
increasing number of injections of 9.1 mg sample injected in 10 injections (Figure 3.7).
This also happened with sample injected up to 22.8 mg with 5 injections (Figure 3.8. to
Figure 3.11). However, all of them still had good resolutions with a value above 1.5.
Sample injected with concentration 45 mg - 47 mg as shown on Figure.3.11 and
Figure 3.12 provided acceptable resolution; however the purities and yields decreased and
the recoveries were low. When the amount of injection was increased two times (91.2 mg);
the peaks of α-mangostin and all other compounds lost resolution and became overlapping
(Figure 3.13). It also affected the purity, yield, as well as recovery which was significantly
down. For this reason the concentration of 22.8 mg ethanol extract (SM-22 on Figure 3.11)
was selected as a sample injected for further study on development of an efficient method
for productions of purified α- mangostin using liquid flow processing.
The percentage of stationary phase left was calculated and presented as initial % SF
as %SF before injection and final %SF as %SF after the last injection. The %SF can be seen
on each fractogram on Figure 3.6 – Figure 3.22 below.
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Table 3.11 Sample loading study on Mini HPCCC (17.4 mL coil; 0.8 mm bore)
Running
Code

Sample
amount per
injection
(mg)

Number
of
Injections

Resolution*
(Mean ±
SD)

Total
α-Mangostin
Isolated (mg)

Throughput
Sample
Process (g/h)

Throughput
α-Mangostin
Isolated (g/h)

Purity
(Mean ± SD)
(%)

Yield
(Mean ± SD)
(%)

SM-20

Recovery
(%)

4.6

5

2.04 ± 0.29

6.6

0.01

0.003

99.59 ± 0.28

99.42 ± 0.53

99%

SM-16

9.1

10

1.98 ± 0.24

36.8

0.02

0.01

97.81 ± 0.57

97.17 ± 2.30

98.75

SM-17

13.7

5

2.24 ± 0.26

22.4

0.03

0.01

98.74 ± 0.88

98.54 ± 0.43

97.05

SM-18A

18.2

5

1.83 ± 0.39

29.5

0.04

0.01

98.50 ± 0.99

97.44 ± 1.27

99%

SM-19

22.8

5

1.82 ± 0.18

30,6

0.06

0.02

98.82 ± 0.18

93.68 ± 1.67

99%

SM-22

45.6

1

1.33

12.7

0.11

0.03

96.87

98.98

60.2

SM-23

47.8

1

1.44

14.2

0.11

0.03

97.85

95.61

57.5

SM-21

91.2

1

0.67

21.7

0.22

0.05

94.69

92.38

67.1

*Resolution of α-mangostin from the component 3
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Figure 3.6 Fractogram of SM-20; Mini-17.4 mL; HEMWat (5:5:10:4 v/v); RP; 2100 rpm; 25⁰C; 1 mL/min; 5 consecutive
injections of the same amount of 4.6 mg ethanol extract in 0.86 mL without any charge of the SP with initial to final %SF=69%
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Figure 3.7 Fractogram of SM-16; Mini-17.4 mL; HEMWat (5:5:10:4 v/v); RP; 2100 rpm; 25⁰C; 1 mL/min; 10 consecutive
injections of the same amount of 9.1 mg ethanol extract in 0.86 mL without any charge of the SP with initial %SF=69% and final
%SF=68%
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Figure 3.8 Fractogram of SM-17; Mini-17.4 mL; HEMWat (5:5:10:4 v/v); RP; 2100 rpm; 25⁰C; 1 mL/min; 5 consecutive
injections of the same amount of 13.7 mg ethanol extract in 0.86 mL without any charge of the SP with initial %SF 69% and final
%SF 62%
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Figure 3.9 Fractogram of SM-18A; Mini-17.4 mL; HEMWat (5:5:10:4 v/v); RP; 2100 rpm; 25⁰C; 1 mL/min; 5 consecutive
injections of the same amount of 18.2 mg ethanol extract in 0.86 mL without any charge of the SP with initial %SF=69% and final
%SF=61%
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Figure 3.10 Fractogram of SM-19; Mini-17.4 mL; HEMWat (5:5:10:4 v/v); RP; 2100 rpm; 25⁰C; 1 mL/min; 5 consecutive
injections of the same amount of 22.8 mg ethanol extract in 0.86 mL without any charge of the SP with initial %SF=69% and final
%SF=61%
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Figure 3.11 Fractogram of SM-22; Mini-17.4 mL; HEMWat (5:5:10:4 v/v); RP; 2100 rpm; 25 ⁰C; 1 mL/min; single
injection of 45.6 mg ethanol extract in 0.86 mL LP with initial %SF=72% and final %SF=56%
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Figure 3.12 SM-23; Mini-17.4 mL; HEMWat (5:5:10:4 v/v); RP; 2100 rpm; 25 ⁰C; 1 mL/min; single injection of 47.8 mg
ethanol extract in 1.8 mL LP with initial %SF=72% and final %SF=52%
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Figure 3.13 Fractogram of SM-21 Mini-17.4 mL; HEMWat (5:5:10:4 v/v); RP; 2100 rpm; 25 ⁰C; 1 mL/min; single injection
of 91.2 mg ethanol extract in 0.86 mL LP with initial %SF=72% and final %SF=40%
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3.11 Efficient Method for Production of α-Mangostin
An efficient method for production of purified α-mangostin using liquid flow
processing was developed based on the results from the sample loading study on an
analytical scale Mini HPCCC instrument that was mentioned above. Using the optimum
concentration of 22.8 mg crude extract on Mini; the sample was then scaled up 8 times on
semi preparative Spectrum HPCCC instrument and 50 times on preparative Midi HPCCC
Instrument for developing an efficient HPCCC method. The running conditions for those
instruments are described on table 3.12 below:
Table 3.12 Optimised conditions for development of an efficient method for
production of α-mangostin using HPCCC
No Parameters

Mini
HPCCC
17.4

Spectrum
HPCCC
143.5

Midi
HPCCC
912.5

HEMWat
(5:5:10:4)
8

HEMWat
(5:5:10:4)
50

1

Coil volume (mL)

2

Solvent system

3

Flow rate (mL/min)

HEMWat
(5:5:10:4)
1

4

Running Mode

Reverse phase

Reverse phase

Reverse phase

5

Temperature (⁰C)

25

25

25

6

Rotational speed (rpm)

2100

1600

1400

7

Elution time /injection 25
(min)
Number of injections
5

25

25

2-10

5-7

358.7

1281.1

7

50

0.05

0.88

8
9
10
11

Extract amount per 22.8
injection (mg)
Sample volume per 0.86
injection (mL)
Throughput α0.02
mangostin Isolated
(g/h)

The method used only one step with multiple injections using the conditions as
described above. This multiple injections without the replacement or topping up of the
stationary phase that occurs in existing method, could save the use of solvents in particular
the volume of stationary phase. It might be simply calculated using the following equation:
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V X = VC ( N − 1)
Where VX is volume of stationary phase saved; VC is volume of column; N is
number of injections.
In addition, multiple injections also saved the wasted time of pre and post CCC
running for each injection i.e. filling the column, equilibration process and emptying the
column. A similar equation is suitable to calculate the time saved as follows,

t X = t E (N − 1)
Where

tX is time saved for column equilibration/emptying; tE is time of column

equilibration/emptying process; N is number of injections.
Using maximum concentration of sample injected for each instrument, this
developed method not only reduced solvent and time consumption of the production
process, reducing the cost of production, but also provided a high throughput with high
purity and yield of α-mangostin as well as high recovery. The multiple injections method
for producing the α-mangostin is efficient with the optimised conditions as shown on Table
3.12.
As in the previous running on Mini, scaling up 8 times on Spectrum and 50 times on
Midi resulted in a similar elution time of α-mangostin at approximately 17 to 23 min. The
scaling up factor is a simply obtained by dividing the bigger column volume with the
smaller one. So the scale up factor is the result of the division between the column volume
on Midi or Spectrum with the Mini column. This factor was then used for calculating the
amount and the volume of the injection as well as the flow rate. Modification with
increasing the concentration or the volume of the sample injected might be possible to
obtaining a higher throughput in production process. However, the flow rate should be
considered and might be reduced during injection time of a large volume or concentrated
sample to avoid losing of stationary phase from the coil, as this leads to loss of resolution.
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Table 3.13 Development of an efficient method for production of α-mangostin using liquid flow processing
Running
Code

Extract
amount
per
injection
(mg)

Instrument

Coil
volume
(mL)

Number of
Injections

Resolution*
Mean±SD

Total
α-mangostin
Isolated (mg)

Throughput
Sample
Process
(g/h)

Throughput
α-mangostin
Isolated
(g/h)

Purity
Mean±SD
(%)

Yield
Mean±SD
(%)

Recovery
(%)

SM-19

22.8

Mini

17.4

5

1.82±0.18

30.6

0.06

0.02

98.82±0.18

93.68±1.67

> 99

SM-27A

22.0

Mini

17.4

5

1.66±0.20

31.3

0.05

0.02

98.09±0.61

97.86±2.78

> 99

SM-28

21.9

Mini

17.4

5

1.59±0.15

38.0

0.05

0.02

98.13±1.11

94.68±3.62

98.6

SM-29

178.3

Spectrum

143.5

5

2.34±0.10

164.1

0.43

0.08

99.19±0.34

95.43±2.97

91.1

SM-30

178.3

Spectrum

143.5

10

2.06±0.30

343.5

0.43

0.08

99.24±0.26

96.35±1.56

> 99

SM-33

358.7

Spectrum

143.5

2

2.24±0.11

43.4

0.86

0.05

99.34±0.43

99.61±0.55

> 99

SM-26

1281.1

Midi

912.5

5

1.73±0.09

1673.4

3.07

0.80

98.32±0.36

95.56±4.56

98.3

SM-28A

1273.8

Midi

912.5

7

1.63±0.18

2552.8

3.06

0.88

98.24±0.82

94.42±4.64

> 99

SM-34

708.6

Spectrum

143.5

3

1.26±0.06

195.1

1.7

0.16

96.38±1.48

94.97±2.14

43.6

SM-37

496.0

Spectrum

143.5

5

1.46±0.21

424.3

1.20

0.20

98.11±1.71

93.81±3.37

81.2

*Resolution of α-mangostin from component 3
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The fractograms at Figure 3.14 to Figure 3.20 described the CCC running during
development of an efficient method for production of α-mangostin using CCC.

The

fractograms shows that α-mangostin was well separated using any scale of CCC apparatus
from analytical to preparative. This can be determined from the values of resolution which
are displayed on Table 3.13. All resolutions were acceptable, with value at least 1.59.
Having a good resolution allowed increasing either the concentration or the volume of
sample injected which means increasing the throughput of sample processing and
production of the α-mangostin as well.
Figure 3.16 to Figure 3.18 shows that the peaks of α-mangostin looked different
with the α-mangostin peaks obtained from samples stored in methanol. Usually αmangostin peak has the highest peak in the fractogram as shown on Figure 3.3. However
in Figs 3.16-3.18, the mangostin peak was smaller than target no 2 especially for the run
SM-33 (figure 3.18) where the sample was the most unfresh one, having been stored for
more than a week in LP. These mean that the ethanol extract of mangosteen was more
unstable in LP than in methanol.
Table 3.13 also presents the purities of α-mangostin produced in one step using any
scale of CCC machine. In general, the Spectrum HPCCC produced the highest purity of αmangostin at >99% compared to those on Mini and Midi, which produced a bit lower
roughly 98%. Although the separation was conducted with 10 injections on SM-30, the
resolution was still very good. It can be seen on Figure 3.17. The α-mangostin was well
separated from the other compounds with resolution value of 2.06 ± 0.30; and obtained
very high purity at 99.24 ± 0.26 % with 96.35 ± 1.56% yield and nearly 100% recovery.
This pure α-mangostin had purity acceptable for use as a reference standard for quality
control of mangosteen based products and also for marker quantitative analysis and
standardization of the raw materials and preparations from mangosteen plant (Pothitirat and
Gritsanapan, 2009). This is very important since mangosteen is one of the medicinal plants
where components often depend on the place where it grew.
Based on the results of Spectrum HPCCC on SM-30, the concentration of sample
injected was increased 2 times to 358.7 mg (SM-33). Two injections with this twice higher
concentration obtained an equal percentage of purity at 99.34 ± 0.43 % with a higher yield
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at 99.34 ± 0.43%. So, the sample injected was then increased again with a larger amount of
496 mg extract in 7 mL with 5 injections (SM-37) and 708.6 mg extract in 10 mL with 3
injections (SM-34). The experiments resulted α-mangostin isolated with the purity 98.11%
and 96.38% by HPLC peak area and the yield 93.81% and 94.97% respectively. However
the recovery decreased to 81.2% on SM-37 and 48.6% on SM-34. It can be concluded that
the production of α-mangostin in preparative scale using Spectrum HPCCC with all
conditions as mentioned above was optimum and α-mangostin was obtained with high
purity, yield and recovery when injecting a sample with the concentration approximately
450 mg / 7 mL (65 mg/mL) aqueous ethanol extract of the fruit rind of Garcinia
mangostana L in LP with maximum volume of 10 mL. α-Mangostin with the purity at
minimum 98% is acceptable to be used as a reference standard for quality control of
mangosteen based products. This method was also efficient because up to 5 injections were
possible without replacement or topping up the stationary phase, the separation was kept in
stable with acceptable resolution value at 1.46±0.21.
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Figure 3.14 Fractogram of SM-27A; Mini-17.4 mL; HEMWat (5:5:10:4 v/v); RP; 2100 rpm; 25⁰C; 1 mL/min; 5 consecutive
injections of the same amount of 22.0 mg ethanol extract in 0.86 mL without any charge of the SP with initial %SF=66% and final
%SF=60%
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Figure 3.15 Fractogram of SM-28; Mini-17.4 mL; HEMWat (5:5:10:4 v/v); RP; 2100rpm; 25⁰C; 1 mL/min; 5 consecutive
injections of the same amount of 21.9 mg ethanol extract in 0.86 mL LP without any charge of the SP with initial %SF=69% and
final %SF=61%
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Figure 3.16 Fractogram of SM-29; Spectrum-143.5 mL; HEMWat (5:5:10:4 v/v); RP-1600 rpm; 25⁰C; 8 mL/min; 5
consecutive injections of the same amount of 178.3 mg ethanol extract in 7 mL LP without any charge of the SP with initial
%SF=93% and final %SF=79%
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Figure 3.17 Fractogram of SM-30; Spectrum-143.5 mL; HEMWat (5:5:10:4 v/v); RP-1600 rpm; 25oC; 8 mL/min; 10
consecutive injections of the same amount of 178.3 mg ethanol extract in 7 mL LP without any charge of the SP with initial
%SF=77% and final %SF=63%
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Figure 3.18 Fractogram of SM-33; Spectrum-143.5 mL; HEMWat (5:5:10:4 v/v); RP; 1600 rpm; 25⁰C; 8 mL/min; 2
consecutive injections of the same amount of 358.7 mg ethanol extract in 7 mL LP without any charge of the SP with initial
%SF=81% and final %SF=68%
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Figure 3.19 Fractogram of SM-26; Midi-912.5 mL; HEMWat (5:5:10:4 v/v); RP; 1400 rpm; 25oC; 50 mL/min; 5
consecutive injections of the same amount of 1281.1 mg ethanol extract in 50 mL LP without any charge of the SP with initial
%SF=85% and final %SF=57%
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Figure 3.20 Fractogram of SM-28A; Midi-912.5 mL; HEMWat (5:5:10:4 v/v); RP; 1400 rpm; 25oC; 50 mL/min; 7
consecutive injections of the same amount of 1273.8 mg ethanol extract in 50 mL LP without any charge of the SP with initial
%SF=82% and final %SF=58%
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Figure 3.21 Fractogram of SM-34; Mini-143.5 mL; HEMWat (5:5:10:4); RP; 1600 rpm; 25oC-8mL/min; 3 consecutive
injections of the same amount of 708.6 mg ethanol extract in 10mL LP without any charge of the SP with initial %SF=76% and final
%SF=38%
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Figure 3.22 Fractogram of SM-37; Mini-143.5 mL; HEMWat (5:5:10:4); RP; 1600 rpm; 25oC-8mL/min; 5 consecutive
injections of the same amount 496 mg ethanol extract in 7mL LP without any charge of the SP with initial %SF=90% and final
%SF=61%
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Identification and characterisation of isolated α-mangostin by NMR was provided
and interpreted by Kingston University, London. The identified sample was from SM 23
which was run with a single injection on Mini. It was a combined pure fractions (F20 and
F21) which had a single peak on analytical HPLC. (Figure 3.23 and 3. 24) 13C-NMR and

1

H-NMR on fractions 20-21 which ran similarly to an α-mangostin commercial reference
standard, indicated α-mangostin. There was a ketone region at the spectral line of 183.1690
ppm, the six spectral lines in the 15 – 30 ppm. range suggesting –CH2 or –CH3 carbons.
The spectral line at 61.9 ppm indicated the presence of a –CH2 or –CH3 attached to an
oxygen while spectral lines in the 90 – 155 ppm range indicated the presence of alkenes,
benzenes or other hetero aromatics. The spectral lines that show up in the 160 – 170 ppm
range indicated the presence of an anhydride of some description or a carbon directly
bonded to oxygen. This spectrum also showed a 24 carbon structure, which fits with αmangostin.
The spectral lines in the 1.6 – 1.8 ranges from proton spectrum suggested the
presence –CH3 protons. The three spectral lines in the 3.0 – 4.2 ppm range suggested the
presence of carbons bonded to nitrogen, oxygen or a halogen; although, in this situation, it
was likely to represent a carbon bonded to oxygen. The large multiplet at 5.2 ppm could
represent a –CH-O or –CH-Halogen pairing, however it could also represent a nonconjugated alkene. The spectral lines between 6 – 8 ppm suggested protons in the aromatic
region while the spectral line at 13.5 ppm suggested the presence of aldehydes.
Looking at the COSY spectrum and HSQC spectrum for EKSM23F2021 and
compared to the standard, it was finally concluded that the sample had chemically structure
of α-mangostin as follows:
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Figure 3.23 Chemical structure of EKSM23F2021 on NMR
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Figure 1 COSY spectrum of a-mangostin standard in chloroform
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Figure 3.25 HSQC spectrum of a-mangostin standard in chloroform
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Figure 3.26 Carbon spectrum of EKSM23F2021 which had a single peak on HPLC was identified as α-mangostin on NMR
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Figure 3.27 Proton spectrum of EKSM23F2021 which had a single peak on HPLC was identified as α-mangostin on NMR
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Figure 3.28 COSY spectrum of EKSM23F2021
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Figure 3.29 HSQC spectrum of EKSM23F2021
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Chapter 4 SUMMARY AND CONCLUSIONS
4.1 SUMMARY
Table 4.1.1 Optimum Conditions for Analysis of α-mangostin on HPLC
No

HPLC
Parameters

1

Column

2
3

Temperature
Flow rate

4

Mobile phase

5

Elution program

6

Run time
Delay time
between injection
Collecting data
Wave length
detection
Low limit of
detection (LLOD)
Retention time of
α-mangostin
(min)

7
8
9
10

11

Optimum Conditions of HPLC
Agilent Zorbax Bonus RP C18 with
dimension (3.5um; 4.6x150mm)
40 ⁰C
0.5 mL/min
Methanol with 0.05% TFA (C)
Water with 0.05% TFA (D)
Gradient system:
0-3 min: 95-100% C;
3-8 min: 100% C;
12 min
2 min
12 min
PDA Max Plot 210 nm to 400 nm
0.000008 µg/µL (8 ppm)

6.00 - 6.50

Table 4.1.2 Optimum conditions of sample loading study
No

Parameters

Optimum Conditions

1

Instrument

Analytical Mini HPCCC

2

Column volume

17.4 mL

3

Bore

0.8 mm

4

Solvent system

HEMWat (5:5:10:4 v/v)*

5

Stationary phase

Upper phase

6

Mobile phase

Lower phase
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7

Elution mode

Reverse phase

8

Rotational speed

2100 rpm

9

Flow rate

1 mL/min

10

Temperature

25 ⁰C

11

Run time per injection

25 min

13

Optimum amount of
sample injected (mg)
Volume of sample (mL)

14

Number of injections

12

22.8
0.86
Up to 10 times

*H stands for hexane
Table 4.1.3 Optimum Conditions for Production of α-mangostin using HPCCC
No

Parameters

1

Coil volume (mL)

2

Solvent system

3

Flow rate (mL/min)

4

Running Mode

5

Temperature (⁰C)

6

Rotational speed
(rpm)
Elution time
/injection (min)
Number of injections
Extract amount per
injection (mg)
Sample volume per
injection (mL)
Throughput αmangostin Isolated
(g/h)

7
8
9
10
11

Spectrum HPCCC

Midi HPCCC

143.5

912.5

HEMWat (5:5:10:4)

HEMWat (5:5:10:4)

8

50

Reverse phase

Reverse phase

25

25

1600

1400

25

25

2-10

5-7

358.7

1281.1

7

50

0.05

0.88
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4.2 CONCLUSIONS
It can be concluded that an efficient method for production of α-mangostin using
liquid flow processing on HPCCC with multiple injections using optimum condition as
mentioned above was as follows:
1.

Multiple injections without replacement or topping up the stationary phase. This could
save solvent use especially on stationary phase equal to the volume of stationary phase
used for the dynamic equilibration multiplied by the following injections number. This
means a lower cost of production.

2.

Reduce time consuming compared to single injection as existing method since any
number of injections only needs once column equilibration and once column
empty/washing. So, it should be faster to isolate the same amount of α-mangostin with
the developed method.

3.

In this research, the most efficient method for production of α-mangostin using liquid
flow processing was on semipreparative HPCCC with the optimum concentration of
sample injected approximately 65 mg/mL with maximum volume of 10 mL per
injection.
The prediction of solvent system and time consumed on various HPCCC

instruments can be seen on the Table 4.1.4 and Table 4.1.5 below:
Table 4.1.4 Prediction of solvent system consumed on various HPCCC instruments
No

Parameters

10 continous injections
Mini

Spectrum

Midi

20

22 and 132

1000

1

Coil volume (mL)

2

Stationary Phase saving for
column equilibration (mL)

9x20=180

3

Mobile Phase saving for
column equilibration (mL)

9x20=180

9x100=900

9x700=6,300

Total solvent saving (mL)

360

2,286

15,300

9x154=1,386 9x1000=9,000
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Table 4.1.5 Prediction of time consumed on various HPCCC instruments
No

Parameters

10 continous injections
Mini

Spectrum

Midi

1

Time saving for column
equilibration (min)

9x15=135

9x15= 135

9x15=135

2

Time saving for column
empty (min)

9x10=90

9x30=270

9x30=270

3

Time saving for column
washing (min)

9x5=45

9x10=90

9x10=90

4

Total time saving (hours)

4.5

8.25

8.25

4.3 FUTURE WORK
The future work that can be recommended regarding this project includes:
1. Scale up for production of α-mangostin on preparative and industrial scale, based on the
optimum concentration of injected sample on Spectrum HPCCC.
2. Separation and isolation of component 4, which had the same UV spectrum but
different retention time to α-mangostin. The isolated compound can then be assayed for
the bioactivities as for α-mangostin because having the same UV active component may
have similar bioactivities. It might be an isomer of mangostin.
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